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LUMBAR   MAGNETIC   RESONANCE   IMAGING   CHANGES   IN   ASYMPTOMATIC   INDIVIDUALS   OF
DIFFERENT   AGE
Matveeva Niki, Lazarova - Tosovska D, Zhivadinovik J, Zafirova B, Jovevska S
Institute of Anatomy, Medical Faculty, University “Ss Cyril and Methodius”, Skopje, R. Macedonia
Abstract
Study Design. A cross sectional study of magnetic resonance imaging changes  (MRI) in asymptomatic
subjects of different age.
Objective. To examine the prevalence of lumbar spine MRI changes in asymptomatic subjects and their
relationship with age.
Background. Previous studies of MRI changes included asymptomatic individuals or patients with low back
pain. The influence of age on the prevalence and pattern of intervertebral disc degeneration within the asymptomatic
adult and old adult population can provide general insight into the etiopathogenesis of spinal degeneration in order to
distinguish early manifestations of a pathologic process  from changes due to the normal process of aging.
Methods. Lumbar spine MRIs were obtained in 152 individuals between 35 to 75 years of age. MRI changes
such as anular tears (HIZ), disc degenerative changes and disc herniations were evaluated by two independent
observers. Degenerative disc changes and herniations were evaluated and graded using  the morphologic criteria
accepted by the Nomenclature Committee of the North American Spine Society. The severity of  degenerative disc
changes  was calculated by the summation of the degenerative scores for each lumbar level, total disc degeneration
score (TDS). The extent of the disc degeneration was determined by the summation of  degenerated disc levels, (NDD)
as number of degenerated discs.
Results. The prevalence of disc degenerative changes in asymptomatic individuals was increasing progressively
to over 90% by the age of 55. The total degenerative score  increased with aging. The number of degenerated disc
levels  also increased with aging.  Disc herniations were not associated with aging. There was no significant influence
of the age on the prevalence of anular tears  (HIZ),  disc bulgings, and disc herniations.
Key words: magnetic resonance imaging, lumbar disc degeneration,  low back pain
Introduction
The intervertebral joint is a three-joint complex
consisting of the endplate-disk-endplate joint of the
anterior column and the two facet joints of the posterior
column supported by ligaments and muscle groups.
The intervertebral disk and the diarthrodial joints
(zygoapophyseal joint or facet joints) interactively
degenerate. This degenerative process causes altered
stresses on the integrity and mechanical properties of the
spinal ligaments, which results in degeneration of the
spinal unit as a whole (1,2).
The term degeneration includes any or all of the
following morphologic changes: real or apparent
desiccation, fibrosis, narrowing of the disk space,
extensive fissuring (ie, numerous annular tears) and
mucinous degeneration of the annulus, defects and
sclerosis of the endplates, osteophytes at the vertebral
apophyses. At magnetic resonance (MR) imaging,
degenerative  changes are manifested by disk space
narrowing, T2-weighted signal intensity loss from the
intervertebral disk, presence of anular fissures,
calcifications within the intervertebral disk,  vertebral
marrow signal changes and osteophytosis.
There is confusion in the differentiation of
changes of the pathologic degenerative process in the
disk from those of normal aging, because abnormal MRI
findings are also common for asymptomatic individuals.
The term degenerative  includes all previous mentioned
changes (3-5). Previous studies of MRI changes included
asymptomatic individuals or patients with low back pain.
Thus the influence of age on the prevalence and pattern
of intervertebral disc degeneration within the
asymptomatic adult and old adult population can provide
general insight into the etiopathogenesis of spinal
degeneration in order to distinguish early manifestations
of a pathologic process  from changes due to the normal
process of aging.
The aim of the study was to examine the
prevalence of lumbar spine MRI changes in asymptomatic
subjects and their relationship with age.
Acta morphol. 2011; Vol.8(2): 7-11
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Material and Methods
A total of 152 subjects were included in the study
(58 females and 94 males). Mean age of  the subjects was
46 years (range 35-75 years). All of the subjects were asked
whether they have ever had a low back pain. Low back
pain was defined in this study as an episode of
nonradiating low back pain that had lasted more than two
weeks. Criteria for inclusion in the study were no history
of low back pain, sciatica or neurogenic caudication.
Subjects who met the inclusion criteria entered the study,
while the MR imaging examination of the lumbar spine
was preformed on the basis of the accepted criteria and
patient’s consent.
MR imaging and disc abnormalities evaluation
MR imaging examination was preformed with 1,5
T MR unit (Gyroscan T10- NT) with a spinal surface  coil.
The imaging protocol consisted of a sagittal T1-weighted
spin-echo sequence (repetition time msec/echo time msec,
600/14; section thickness, 4 mm; field of view,  280x280
mm; matrix,  240 x 256),  sagittal T2-weighted turbo spin-
echo sequence (4,700/120; section thickness, 4 mm;
intersection gap, 0.8 mm; echo train length of 15), and a
transverse T2-weighted turbo spin-echo sequence at one
or multiple levels  (4,500/120; section thickness, 4 mm;
intersection gap, 0.8 mm; echo train length of 15; field of
view, 200x200 mm; matrix 240 x 256). Depending on the
pathologic condition transverse T1 weighted spin echo
was preformed after administration of  Gd-DTPA
(Magnevist). The obtained MR images were assessed in
consensus by two radiologists.
Using a well defined morphologic nomenclature
disc abnormalities were evaluated and classified based
on the morphologic criteria accepted by the Nomenclature
Committee of the North American Spine Society (6).
Lumbar intervertebral disc degeneration was evaluated
on the basis of signal intensity changes  and disc height.
Disc degenerative changes were graded employing 3 point
graded system, DDS (Disc Degeneration Score). Grade 1
represented slight decrease in signal intensity from the
disc, grade 2 represented generalized hypontense disc
signal and grade 3 represented generalized hypontense
disc signal with narrowing of the disc height. Two
additional scores were developed to indicate the severity
of degenerative disc disease and the extent of the
degenerative disease. TDS (Total Disc Degeneration Score)
was derived by summing the scores of all 5 lumbar
intervertebral disc levels. A minimum TDS of 0,  would
mean that all 5 levels were not degenerated, and a maximum
TDS of 15, would mean that all 5 levels were severely
degenerated (grade 3). TDS < 4 was considered as mild
degeneration, TDS ranged from 4 to 7 was considered
moderate, while TDS e” 7 was considered as severe
degeneration.The extent of the degenerative disc disease
was represented by NDD (Number of Degenerated Discs
), that was determined as the number of levels with disc
degeneration scores (DDS) that were grade 2 or higher.
Disc herniatons were evaluated as  disc
protrusions, or extrusions. Anular tears were identified as
areas of high signal intensity surrounded by a dark rim
Statistical analysis was made with by SPSS  13.0
software. One factor analysis  of variance (ANOVA) was
used to examine the influence of age on disc degenerative
changes and on disc herniations.
Results
A total of 152 subjects were included in this study,
divided in four age groups (35-44, 45-54, 55-64 and 65 and
older).
Lumbar Disc Degeneration by Age
Figure 1 shows the proportion of subjects with
mild, moderate and severe lumbar disc degeneration by
age. The percentage of subjects with severe lumbar disc
degeneration increased with age. Thirty six percent of
subjects in the age group of 35 to 44 years had mild disc
degeneration (Total Disc Degeneration Score (TDS)<4),
while 57 % of the subjects from this age group had
moderate disc degeneration (4<TDS<7). Severe disc
degeneration (TDS > 7) was seen in 58% of the subjects in
the 55 to 64 years age group, and in 80% of the subjects
aged 65 and older. Only 20% of old adults had moderate
disc degeneration.
Using ANOVA, mean TDS (Total Disc
Degeneration Scores) were significantly different  between
different age groups ( F=42,89, p=,00). Mean values of
TDS were the lowest in the first age group and  the highest
in the  age group  > 65 (Fig.2). The differences  between
the mean values of TDS were the most significant between
the third and the other 3 age groups and between the
oldest age group and the other 3 age groups.
Disc levels and age
Not only the severity of disc degeneration, but
the number of levels with disc degeneration also increased
with age (Figure 3).  The majority of subjects aged 35 to 44
years had 1 to 2 levels of disc degeneration, 68% of the
subjects aged 35 to 44 years had two levels of disc
degeneration, whereas 68% of subjects aged 55 to 64 years
had four levels of disc degeneration. In approximately 70%
of old adults 5 levels of disc degeneration were found.
Using ANOVA, mean NDD (Number of
Degenerated Discs) were significantly different  between
different age groups ( F=45,67, p=,00). Mean values of
Matveeva N. Lumbar magnetic resonance imaging changes in asymptomatic individuals of different  age
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NDD were the lowest in the first age group and  the highest
in the  age group  >  65. The differences  between the mean
values of NDD were the most significantlyexpressed
between the oldest age groups and the other 3 age groups.
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Degeneration Score of 2 and greater) stratified by age.
Disc herniations, disc bulges, HIZ  and age
Disc herniations ( protrusions and extrusions)
were found most commonly in subjects aged 45 to 54 years,
33%. Also 26% of subjects aged 45 to 54 yers had disc
herniations. Disc herniations were not observed to
increase with aging. Disc bulges were found in 38% of
subjects aged 45 to 54 years. Disc bulges  were not age
related findings in adults and old adults  (Fig.4). Anular
tears were found in 10% of the subjects 35 to 44 years old,
but the percent of the subjects with positive MR finding
of HIZ slightly decreased to  6,8% in the subjects aged 55
to 64 years. Using ANOVA the number of discs with
positive MR findings of HIZ , as well as the number of
herniated discs  were not significantly different between
the different age groups
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Fig.4. Proportion of subjects with MR evidence of disc
bulgings and disc herniations stratified by age.
Matveeva N. Lumbar magnetic resonance imaging changes in asymptomatic individuals of different  age
  10
Discussion
The results of this study confirmed that disc
degeneration is increasing  with aging. Disc degenerative
changes  were found with high prevalence in all adult age
groups and in old adults. These findings suggested that
also other factors than age are involved in the
ethiopathogenesis of disc degeneration. Mechanical
stresses and nutritional factors are related to  disc
degeneration process. In addition to mechanical and
nutritional causes, a genetic predisposition has been
suggested by animal models that consistently develop
degenerative disk disease at an early age. Reports of familial
osteoarthritis and lumbar canal stenosis in humans also
confirmed genetic predisposition (7). Some authors
concluded that disk degeneration may be explained
primarily by genetic influences and by unidentified factors,
which may include complex unpredictable interactions.(8).
Individuals with absence of disc degeneration were also
evaluated in adults aged 35 to 44 years. Most of adults
and old adults have MR scans characterized with lumbar
disc degeneration, hence  this changes should be analized
considering the clinical simptamotology. The study used
derived scores in order to quantify the severity of disc
degeneration. There was a significant correlation between
the aging and the severity of the degenerative disc
disease. This method of semiquantitative assessment of
disc degeneration have been used in other studies in order
to identify predisposing genes for disc degeneration (9,
10). Aging  could be an additional factor that contributes
in developing the severity of the degenerative process in
genetically predisposed individuals. In addition to the
changes in the severity of the degenerative process , the
number of affected levels also increased with aging. Aging
is an additional factor that contributes in spreading the
degenerative process, that affect almost the entire lumbar
spine in advanced age.
On the other hand, disc herniations had no
significant age correlation. Other factors like trauma could
have more important role in developing disc herniations.
In a study of symptomatic patients, the prevalence of disk
herniation in patients with low back pain and those with
radiculopathy at presentation was similar (11). Some
authors reported a higher prevalence of herniation, 57%
in patients with low back pain and 65% in patients with
radiculopathy, than the 20%–28% prevalence reported in
asymptomatic series (12, 13). Our study showed a
prevalence from 25 to 33% in adult asymptomatic
individuals.
The limitation of this study were that we couldnot
be certain that the subjects involved in this study were
representative of the entire population of adults and old
adults in terms of the influence of different risc factors,
such as smoking, physical activity, proffesion,
psychosocial variables  that could be additional factors
that contribute to the  development of degenerative disc
process.
Key points
The severity of lumbar disc degeneration  is
increasing with aging. The number of degenerated disc
levels  also increases with aging.  The prevalences of disc
herniations, disc bulging and anular tears (HIZ) are not
associated with aging. There is no significant influence
of the aging on the prevalence of anular tears  (HIZ),  disc
bulging, and disc herniations.
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CLINICAL  IMPORTANCE  OF  THE   ANATOMY  OF  CORONARY  SINUS  OSTIUM
Zhivadinovik Julija, Lazarova - Tosovska D, Papazova M, Matveeva N, Dodevski A
Institute of Anatomy, Medical Faculty, Skopje, R. Macedonia
Coronary sinus (sinus coronarius - CS) is the
main cardiac vein and it has become a clinically important
structure especially for its role in providing access for
different cardiac procedures.
Historically, the main topic of the cardiac vascular
studies was the coronary artery circulation. Although, the
coronary venous system has not been studied as thorough
as the coronary arteries, it is very important in many
electrophysiological procedures, including ablation
procedures of the arrhythmia source,  for mapping,
biventricular pacing, and for deployment of an array of
cardiac devices (1,2,3,4,5,6,7). Anatomical approach to
atrioventricular nodal re-entrant tachycardia (AVNRT)
ablation based on the triangle of Koch is the standard
technique now, with a success rate close to 99%. All these
facts make the understanding of CS anatomy necessary
(8, 9, 10).
This review will describe the basic gross and
developmental anatomy of the CS, its ostium and cardiac
venous supply with particular emphasis on specific
anatomical aspects that are encountered in invasive and
interventional settings.
Anatomical features of the coronary sinus
The coronary sinus - CS is a wide venous
channel, about 2.5 - 5cm. in length, which dependent on
the site of the drainage of the posterolateral vein (11). It is
situated in the left, diaphragmatic part of the
atrioventricular (coronary) sulcus, and is covered with
muscular fibers from the left atrium. The CS begins
proximally at the left atrial auricle, as a continuation of the
great cardiac vein,  at the valve of Vieussen’s,  and ends in
the right atrium, between the opening of the inferior vena
cava (v. cava inferior) and the atrioventricular aperture
(ostium atrioventriculare dex.). Its orifice is often guarded
by a semilunar valve of the coronary sinus (valve of
Thebesius).
The diameter of the CS is variable and
dependents on the loading conditions, presence and extent
of atrial myocardium with the coronary vein, and  presence
of underlying cardiac disease or prior cardiac surgery.
The wall of the CS is covered by the striated myocardium
that is continuous with the atria, forming a myocardial
sleeve around the venous system. 
The CS ostium (ostium sinus coronarii - OSC)  is
5–15 mm in diameter and is located on the lower posterior
part of  the interatrial septum anterior to the Eustachian
ridge and valve, and posterior to the tricuspid annulus,
forming the base of the triangle of Koch (12). 
The CS, like the rest of the cardiac venous
system, contains various valves (13, 14).
The valves can be found at various locations. Most
common are at the ostium of the CS (Thebesian valve)
and at the ostium of the postural lateral vein at the junction
of the great cardiac vein and CS (Vieussen’s valve). These
valves cover different portion of the area of the orifice.
The Thebesian valve is a crescent shaped
structure often found guarding the mouth of the CS as it
opens to the right atrium. This valve is highly variable
and occasionally may present an obstruction during
cannulation of the CS. The degree of development of the
Thebesian valve varies. There are different clasifications
that describe the morphology of the valve. According to
Karaca et al. the Thebesian valve can be present or absent.
If there is the valve, then it may cover different degree of
the ostium (0-100%), and depending on the shape it can
be crescent, semilunar or band shaped (15). Of the
specimens Karaca et al. examined 31%  had crescent, 29%
semilunar, 4% fenestrated and 4% band shaped valve. In
1991, Jatene et al. published an anatomic study of the
Thebesian valve in 94 human hearts. They described four
categories of development of the valve: absent, residual -
covering less than 15% of the OSC, partial - covering more
than 15% of the OSC and trabecular or double (16). D‘Cruz
and Shirwany made a classification that combines the
shape and the degree of the development of the valve (16,
17, 18). According to them, 45% of the specimens had
partial valve that covered more than 15% of the OSC, 31%
had residual valve that covered less than 15% of the OSC,
and 8% had fenestrated or trabecular valve.
Tributaries of the coronary sistem
The myocardium drains mainly by two groups of
veins: the tributaries of the greater and smaller cardiac
veins, or the Thebesian veins. Most of these veins open
into the coronary sinus. The CS receives blood from the
ventricular veins during ventricular systole and empties
into the right atrium during atrial systole (19).
The tributaries of CS are the great, small, and
middle cardiac veins, the posterior vein of the left ventricle,
and the oblique vein of the left atrium, all , except the last
one, havevalves at their orifices.
The great cardiac vein (v. cordis magna; “left
coronary vein”) begins at the apex of the heart and
ascends along the anterior interventricular sulcus to the
Acta morphol. 2011; Vol.8(2):12-15
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base of the ventricles. It then curves to the left in the
atrioventricular sulcus, and reaching the diaphragmatic
surface of the heart, opens into the initial portion of the
coronary sinus. It receives tributaries from the left atrium
and from both ventricles: one, the left marginal vein (v.
marginalis sin), is of considerable size, and ascends along
the left margin of the heart.
The small cardiac vein (v. cordis parva; “right
coronary vein”) runs in the atrioventricular sulcus
between the right atrium and ventricle, and opens into the
enlarged right part of the coronary sinus. It receives blood
from the diaphragmatic surface of the right atrium and
ventricle; the right marginal vein ascends along the right
margin of the heart and joins it in the atrioventricular
sulcus, or opens directly into the right atrium.
The middle cardiac vein (v. cordis media)
commences at the apex of the heart, ascends in the
posterior interventricular sulcus, and ends in the coronary
sinus near its right portion.
The posterior vein of the left ventricle (v.
posterior ventriculi sinistri) runs on the diaphragmatic
surface of the left ventricle to the coronary sinus, but may
end in the great cardiac vein.
The oblique vein of the left atrium (v. obliqua
atrii sinistri - Marshalli; oblique vein of Marshall) is a
small vessel which descends obliquely on the back of the
left atrium and ends in the coronary sinus near its left
portion; it is continuous above with the ligament of the
left vena cava (lig. venæ cavæ sinistræ vestigial fold of
Marshall), and the two structures form the remnant of the
left Cuvierian duct.  
The following cardiac veins do not end in the
coronary sinus:
1. The anterior cardiac veins, comprising three
or four small vessels which collect blood from the front of
the right ventricle and open into the right atrium; the right
marginal vein frequently opens into the right atrium, and
is therefore sometimes regarded as belonging to this
group;
2. The smallest cardiac veins (veins of
Thebesius), consisting of a number of minute veins which
arise in the muscular wall of the heart; the majority open
into the subendocardium of atria, but a few end in the
ventricles. The Thebesian veins are composed primarily
of endothelial cells, which are continuous with the lining
of the cardiac chambers (20). These vessels are found
throughout all four chambers of the heart, but are more
prominent on the right. This venous system provides
drainage to the right appendage as well as a significant
portion of the muscular ventricular septum.
Development of the coronary sinus
Development of the CS occurs by differentiation
of the sinus venosus During foetal development, a single
heart tube separates around the third week giving rise to
the primordial atrium and sinus venosus. Initially, the sinus
venosus opens into the posterior wall of the right atrium.
Around the fourth week, the sinus venosus differentiates
into right horn and left horns which through a process of
degeneration and involution, give rise to the venous
channels entering the right atrium. The right horn persists
as the smooth portion of the superior vena cava as well as
the area between the vena cava extending into the CS
ostium, whereas the left horn undergoes progressive
involution until the 10th week. When the left horn persist
it gives rise to the CS (21, 22).
Clinical importance
Although various types of congenital cardiac
malformations have been well studied, anomalies involving
the coronary sinus have received relatively little attention;
this is probably due to their extreme rarity and that they
can occur without clinical symptoms and without a
significant cardiac functional disturbance. However, in
some situations, the failure to recognize such venous
anomalies may cause a misinterpretation of cardiac
catheterization findings (23, 24), affecting the distribution
of retrograde cardioplegia in patients requiring a
cardiopulmonary bypass (23, 25), and may cause a
troublesome hemodynamic alteration during cardiac
surgery (23, 26).
Most reported cases of coronary sinus anomalies
are diagnosed either during autopsy (25, 27) or by a
transesophageal echocardiogram, magnetic resonance
imaging (28), and by the use of coronary sinus angiography
(28). Multi-detector row computed tomography (MDCT)
technology provides a noninvasive alternative to evaluate
a cardiac malformation comprehensively. Unroofed CS,
engorged CS with atresia of the right atria ostium and
coexisting tubular communication to the left atrium,
anomalous drainage of the v. cava superior into CS,
anomalous pulmonary venous connection to the CS, and
atypical coronary course with presence of a valva of
Vieussens are among the reported anomalies of the CS.
Left superior vena cava (LSVC) (left horn sinus venosus
persistens) draining into coronary sinus is not an
uncommon anomaly that enlarges the coronary sinus. The
enlargement of the coronary sinus distorts the anatomy
of triangle of Koch, making slow pathway ablation difficult.
Total upper body drainage via left superior vena
cava into coronary sinus (i.e. absent right superior vena
cava) is rare anomaly and it further distorts the anatomy
of coronary sinus and triangle of Koch.
The OCS is of interest to the electrophysiologist
because it provides a useful route for mapping and ablation
of left-sided accessory pathways. Nevertheless, pathways
that are located close to the mitral valve may be difficult
to ablate given their significant distance from the OCS. In
addition, the OCS is an electrophysiologically active
structure. Previous studies have demonstrated the
capability of spontaneous depolarization and slow
conduction in the smooth muscle of the CS, providing
inherent automaticity (29, 30, 31). Also, the atrial
myocardial sleeve that covers the proximal CS provides
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the ability for conduction and automaticity, forming an
electrical connection between the two atria. Studies have
shown that this connection is of clinical importance as it
may be a source of arrhythmias such as atrial fibrillation
(32). Active myocardium within the CS may serve either
as a source for abnormal automaticity generating a focal
tachycardia or as a part of a reentrant circuit. In patients
with atrial fibrillation, CS myocardium may also initiate
recurrent atrial fibrillation. Since the CS is one of the
connections between the right and left atria, with
Bachmann’s bundle forming the other important
connection, reentrant tachycardia involving the CS muscle
and both atria are sometimes seen in patients with marked
atrial enlargement, especially after a surgical maze
procedure.
The vein of Marshall may give rise to atrial
fibrillation either by virtue of myocardial extensions into
the structure or as a result of node like remnants within
the vein or by virtue of the rich autonomic innervation
that typically encapsulates the structure (30, 31, 32). With
regard to left ventricular pacing, atrial electrograms may
be sensed by the ventricular lead if it is placed too proximal
(basal) within a ventricular branch of the CS.
Cannulation of the CS during interventional
procedures may be complicated by obstruction due to
Thebesian valves. A three-dimensional, functional
anatomy study showed that Thebesian valve morphology
varied greatly, and included instances of dynamic
obstruction (33). Cannulation would be likely to be more
complicated in the living heart during the cardiac cycle.
Studies have demonstrated that valves that obstruct a
significant portion of the CS ostium may be successfully
transversed by use of modern cannulation techniques (i.e.
softer-tipped sheath, pre-shaped sheath, and anterior
approach) (34).
Our experiance
At the Institute of Anatomy, Medical Faculty in
Skopje the postmortem study of the valve of the OCS  on
100 human hearts without malformations fixed in
formaldehide was made (35). We thought that the most
adequate classification to be applied was that of D‘Cruz
and Shirwany. The results showed the valve was present
in 86% of the cases. The valve was moderately developed
(residual) in 25% of the specimens, well developed (partial)
in 40% and fenestrated in 5.8% of the cases. One specimen
had a valve that looked like chordae tendinae, and thin
fibers crossed over the ostium, connecting the Eustacian
valve with the lower limb of the ostium. The mean value of
the diameter of the OSC was 9.33 mm. (36).The postmortem
studies made on hearts with cardiac malformations
showed the presence of unroofed CS and anomalous
pulmonary venous coconnection to the CS (36).
The knowledge of the anatomy of the OSC and
its valve as one segment of the right atrium is fundamental
for successful realization of therapeutic, diagnostic and
invasive methods in cardiology.
Key words:coronary sinus, cardiac veins,
anatomy
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RADIOLOGICAL   EVALUATION   OF   ANTERIOR
 ETHMOIDAL  SINUS   CELLS
Bojadzieva Biljana, Papazova M, Nakeva Janevska N,
Matveeva N, Cadikovska E
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Abstract
Preoperative radiological-anatomic evaluation of anterior ethmoid sinus cells is important because of their
location near to very important structures like nasolacrimal duct and ethmoid infundibulum. Their identification on CT
of paranasal sinuses is important to avoid complications while performing functional endoscopic sinus surgery (FESS)
and to make association with obstruction of drainage ostia.
In this study we evaluate variations of anterior ethmoid sinus cells on coronal CT scans of 120 examinees of
Macedonian nationality at the age of 17 to 70. CT was performed on CT scanner Somatom, Volume Zoom, Siemens,
multislice 4, at the Institute of Radiology, Medical Faculty, Skopje. The prevalence of anterior ethmoid cells (agger nasi
cell, Haller cell and large bulla ethmoidalis) was evaluated on CT scans as being present separately as unilateral or
bilateral.
The most present anterior ethmoid cells were agger nasi present in 86% of patients bilaterally. Haller cells were
found in 22% of patients on the left side and in only 17% on right side of nasal cavity.  Bulla ethmoidalis left and right was
present with  12% and 18%, respectively the difference in percentages of the presence of agger nasi cells, Haller cells and
bulla ethmoidalis, according to sex, was statistically insignificant for p>0.05.
Key words: paranasal sinuses, anatomical variations, ostiomeatal region, computed tomography
Introduction
Ethmoid paranasal sinus is the most complex of
paranasal sinuses and is known as ethmoid labyrinth,
localized between orbit and nasal cavity, above the maxilla
and below frontal bone. Ethmoidal paranasal cells don’t
develop until 5 lunar month (1). In newborns they are
very small. In the second year in children the
pneumatisation of the nasal cavity is toward the future
frontal sinus, which appears at the age of 3 (2). They
continue to grow until late adolescence, or until sinus
wall touch the compact bone. After the age of 9 the
pneumatisation of ethmoid cells becomes more extensive
and it is not followed by pneumatisation of frontal sinus.
That’s why sometimes ethmoid cells are not covered with
frontal bone and they form the floor of anterior cranial
fossa, covered only with dura mater. In such cases one
should be careful when anterior ethmoidectomy is
performed not to injure the endocranium (2).
Variations of ethmoid cells are due to different
extension of ethmoid cells pneumatisation until they touch
the compact bone (3). Their clinical significance is very
important because they can be the reason for sinusitis
and complications and general diseases. There are 10-15
ethmoid cells separated with thin lamellar bone and
grouped in anterior and posterior cells. Bone lamella that
separates the cells does not allow the sinusitis to be spread
from one to another cell. They are called with different
names and are very often findings on CT scan of paranasal
sinuses. They can be found on the medial wall of the orbit
- agger nasi cell and large bulla ethmoidalis, laterally from
sphenoid sinus- Onodi cells and on the roof of maxillary
sinus - Haller cells. They are normal anatomical variations
except in cases where they cause narrowing of the normal
drainage openings of paranasal sinuses and cause
disturbance of draining sinus secret and sinusitis.
Material and Method
CT scans of 120 examinees of Macedonian
nationality at the age of 17 to 70, 59 women and 61 male
were evaluated. CT was performed on CT scanner
Somatom, Volume Zoom, Siemens, multislice 4, at the
Institute of Radiology, Medical Faculty, Skopje. Coronal
sections were obtained at 3 mm distance, from anterior
wall of frontal sinus to posterior wall of sphenoid sinus.
A total of 120 CT scans were analyzed with normal
anatomy of paranasal sinuses. The patients with
nasopharyngeal tumour, polyps, mucosal hypertrophy,
fractures, earlier operation on the face which interrupt the
normal anatomy of sinuses or lead to ostial destruction
were excluded from the study. The presence of anterior
ethmoid cells: agger nasi cell, Haller cell and large bulla
ethmoidalis were evaluated on CT scans as being present
on both sides of the nasal cavity, separately as unilateral
or bilateral.
Results
We evaluated presence of agger nasi cells, Haller
cells and large bulla ethmoidalis on CT scans of paranasal
sinuses. The examined group consisted of 61 male, and 59
female patients, at the age of 17 years to 70 years.
The most present variation was agger nasi cell,
in 84% of the examinees on the right side and in 86% on
the left side of the nasal cavity (Fig.1). Prevalence of
unilateral presence of agger nasi cell was 3.0, and
bilaterally 86.0.
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Agger nasi cells
Fig.1.  Agger nasi cell present bilaterally, and septal nasal
deviation on left side of nasal cavity.
Haller cells
Fig.2.  Haller cell on the right side of nasal cavity
Haller cells were present in 22% on the left and
17% on the right side of the nasal cavity. Prevalence of
unilateral presence of haller cell was 11.0, and bilaterally
13.0 (Fig.2).
Bulla ethmoidalis
Fig.3.  Large bulla ethmoidalis on the left side of nasal
cavity (unilaterally)
Bulla ethmoidalis left and right were registered
in 12% and 18% of the examinees (Fig.3). Prevalence of
unilateral presence of bulla ehtmoidalis was 13.0, and
bilaterally 8.0.
Discussion
There are many anatomical variations of ethmoid
sinus cells seen on CT scan of paranasal sinuses (4).
According to radiological studies, variations are equally
present in patients with and without pathology of sinus
lining (4, 5, 6). Variations of ethmoid cells are due to different
extension of ethmoid cells pneumatisation until they touch
the compact bone (3,7). Ethmoid cells pneumatise also
frontal bone, maxilla and sphenoid bone and continue with
the sinuses in these bones. Variations in developing of
ethmoid labyrinth appear in relation to dimensions and
position of bulla ethmoidalis, present agger nasi cell, Haller
cell and Onodi cell. Individual cell can be isolated in group
when it’s drainage opening is far from the other cells
openings or there is no communication between the cells.
Therefore spreading inflammation of sinus lining is
important and it’s not a rare phenomenon the inflammation
of ethmoid sinus to spread to maxillary, frontal or anterior
ethmoid cells or not to spread to bulla ethmoidalis which
has isolated opening (3). According to Krmpotic-Nemanic
et al. it is difficult to perform FESS when there is large
bulla ethmoidalis or agger nasi cells (8).
Agger nasi cells are anterior ethmoid cell found
below the frontal sinus on the lateral wall of nasal cavity
and anterosuperoior of hiatus semilunaris (9). Their clinical
meaning was first recognized by Brunner et al. in 1996
whose research showed that excess pneumatisation of
the agger nasi cells and it is close relation to frontal recess
and lachrymal bone, can cause narrowing of the frontal
recess and pneumatisation of lachrymal bone. That is the
main and clinically the most important reason for pain in
frontoethmoid region, chronic frontal sinusitis, or flow of
tears (4). According to Van Alyea they are present in 89%
of the examinees (3). K. Dua et al. found presence of these
cells in 40% unlike Bolger et al. who found presence of
these cells in 88,5 % of patients(10,11). In our study, agger
nasi cells were registered in 86% on the right and 87% on
the left half of the nasal cavity of our examinees. The
prevalence of unilateral presence of agger cells was only
3%, and bilaterally 86%.
Haller cells or the so called infraorbital ethmoidal
cells are localized on the roof of the maxillary sinus, or the
floor of the orbit. They are found in the area of the opening
of the maxillary sinus, in the lower part of lamina papyracea,
laterally from processus uncinatus (4). Halle defined these
cells in 1765. Their presence varies from 9% to 46%.
According to Benjapour they are unilaterally found in 18,2
% of the cases and bilaterally in 14,8%, Bolger et al. found
45,9% Haller cells and Caughely et al. in 27% of the
examined group (10,12,13). Our results showed, Haller cells
20% of the examinees had Haller cells, on the left and 17%
on the right side of the nasal cavity. According to some
authors they are a predetermining factor for maxillary sinus
inflammation.
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Bulla ethmoidalis is the biggest and the most
constant frontal ethmoid air cell which causes prominence
of the lateral wall of the nasal cavity. In Latin “bulla” means
hollow bone prominence. It is developed by
pneumatisation of the second basal ethmoid lamella. The
opening of bulla ethmoidalis is located above, under the
juncture of the middle turbinate, so there is a smaller
possibility, compared to the other cells, that the opening
will be narrowed or obstructed by the surrounding
structures, except in the presence of concha bullosa (3). It
can be enlarged because of hyper pneumatisation and it
can be present unilaterally or bilaterally. Filho et al.
discovered it in 4%, Bolger et al. in 2,5 % of the examinees,
whereas K.Dua et al. in 8% and 6%  of the examinees
bilaterally (10,11,14). In our study enlarged bulla
ethmoidalis left and right was registered in 11% and 18%
of the examinees, respectively when performing FESS in
this region surgeons should be careful not to harm the
orbit through the lamina papyracea (15).The prevalence
of the unilateral presence of bulla ethmoidalis is 13%, and
bilaterally 8%.
In the last three decades the use of computerized
tomography in diagnostics of sinonasal diseases enables
very precise visualization of ethmoid pneumatised cells
and their extension in near bone structures. Because they
are very often present they can be  called normal
variations, except in cases when they cause narrowing of
the drainage sinus openings and in cases when they lead
to disturbance in drainage of sinus secrete.
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Abstract
The aim of this study was to analyze the tortuosity of the vertebral artery and to emphasize the clinical
importance of tortuosity. The data derived from this study will add important contribution to our anatomical knowledge,
but they will also find clinical applications in radiology and surgery.
We examined 40 patients with CT angiography and analyzed the tortuosity of the vertebral artery.
Of the vessels examined, 22 (55%) followed a relatively straight course from their origin to their entry into the
transverse foramen. The other 18 (45%) patients showed some form of tortuosity.
Both vertebral arteries showed high incidence of tortuosity. Our study has highlighted the possible role of
vertebral artery tortuosity in diagnostic and surgical procedures in order to prevent vertebral artery injury.
Key words: anatomy, vertebral artery, tortuosity, surgery.
Introduction
Vertebral artery is the first and the largest branch
of the subclavian artery arising from the posterosuperior
aspect of its first part. It runs upwards and backward in
the scalenovertebral triangle formed by muscles scalenus
anterior and muscles longus colli. The common carotid
artery and the vertebral vein are in front of it. It is crossed
by the inferior thyroid artery and by the thoracic duct on
the left side and the right lymphatic duct on the right side.
The seventh cervical transverse process, the inferior
cervical ganglion and ventral rami of the seventh and eight
cervical spinal nerves lie posterior to the artery. Then the
vessel reaches the sixth cervical vertebra to enter into the
foramen of transverse processus. It passes through the
foramina in the transverse processes of all of the cervical
vertebrae except the seventh, curves medially behind the
lateral mass of the atlas and enters the cranium via the
foramen magnum. At the lower pontine border it unites
with its contralateral fellow to form the basilar artery [1].
The vertebral artery is divided into four
segments. The segment of the artery from its origin at
subclavian artery to its entry into the respective transverse
foramen is called the pretransverse, prevertebral or V1
segment. Between its origin and its entrance into the
transverse foramen, the segment of the vertebral artery
may show some tortuosity which can take a variety of
forms and occupy several orientations [2].
The vertebral artery is formed between the 32nd
and the 40th gestational day (7-18 mm embryo) from fusion
of secondary persistent segments of cervical arteries and
the primitive dorsal aortic arch. It is possible that
abnormalities in fusion contribute to some tortuosities of
the vessel. An abnormal origin is a rare finding; on the
other hand, tortuosity is much more common. Whether
this is from congenital origin or not, we can only speculate
[2].
The aim of this study was to describe the
tortuosity of the vertebral artery, to emphasize the clinical
importance of tortuosity and to provide basic information
for further clinical studies. Before undertaking any
surgeries in the cervical region, a thorough knowledge of
the surgical anatomy of the vertebral artery is mandatory
to avoid a potentially catastrophic injury to a vertebral
artery and to take decisions on the appropriate corrective
surgery options [3].
Material and Methods
Forty patients from the University Clinic for
Radiology in Skopje, R. Macedonia were investigated
during a period of 8 months, from February 1st 2010 to
September 30th 2010. For the purpose of this study 17
females and 23 males, ranging in age between 19 and 75
years, mean age of 54.1±12 years, were examined.
Anatomical analysis of CTA images realized for
medically justified goal was done. Patients were
investigated with computed tomography angiography
(CTA). CTA was performed with CT scanner Somatom,
Volume Zoom, Simens, multislice 4. Contrast material was
injected by using intravenous catheter placed in the
peripheral vein, a total of 100 ml. at a rate of 3 ml/s with a
pressure injector. After the contrast medium was injected,
by use of bolus tracking software, scanning was carried
out automatically. The data were transferred to a
workstation for post-processing. Reconstruction included
the following: maximum intensity projection-MIP; four-
dimensional CTA with volume rendering; reformatted
multiplanar reformation-MPR.
By using the CTA we received 40 high quality
images, which met the requirements of our study. Eighty
vertebral arteries of the 40 patients were analyzed for
tortuosity of the vertebral artery. The path of the vertebral
artery was studied in detail, any form of tortuosity was
noted; the plane of tortuosity was also examined.
Results
Of the vessels examined, 22 (55%) followed a
relatively straight course from their origin to their entry
into the transverse foramen (Fig. 1). The other 18 (45%)
patients showed some form of tortuosity (Fig. 2). The plane
of tortuosity was transverse in 50%, sagittal in 27.7% and
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frontal in 22.2%. Bilateral tortuosity was encountered in
10 patients and unilateral in 8 patients (5 on the left side
and 3 on the right side).
Discussion
From the point of origin toward foramen of
transverse processus of the vertebrae, vertebral artery
may show different level of tortuosity [4].
Tortuosity of a vertebral artery used to be
considered a rare abnormality, but recently its frequency
has increased. The left vertebral artery is involved more
often than the right one. This may be related to the fact
that the left vertebral artery is larger than the right in a
higher percentage of individuals. Rarely, bilateral or
multilevel tortuosity of the vertebral arteries occurs with
corresponding radiologic findings [5, 6, 7, 8].
Matula et al. in their series found that in 61% of
the cases the vertebral artery followed non-tortuous path
from the origin to the transverse foramen and in 39%
followed a tortuous path. Furthermore, they classified
tortuosity according to the geometric plane as horizontal
(44.9%), sagittal (33.7%), and frontal (21.4%). In 32.5% of
the cases the contorted pathway was on the right side,
and in 68% of the cases, on the left. [2].
Trattnig et al. in their series found that 52.8% of
the examined vessels, followed a relatively straight course
from their origin to their entry into the foramen
transversarium, but 47.2% showed some form of tortuosity
(one coil at most). The main plane of the tortuosity was
transverse in 42.5%, sagittal in 30% and frontal in 27.5%
plane [4].
Poonam et al. in their series found that a total of
31 vertebral arteries (22.1%) showed the tortuous pathway
in 25 cadavers. Bilateral tortuosity was encountered in six
cadavers and unilateral tortuosity in 19 cadavers (13 on
the left and 6 on the right). Twenty-six vertebral arteries
had a single coil tortuosity and five vertebral arteries had
a double coil tortuosity. The maximum number of
tortuosities was observed in the transverse plane,
followed by tortuosity in the sagittal plane [9].
Fig. 1. Straight course of the vertebral artery
Sastry et al. observed tortuous course in nine
cases or 23.7% and in all cases the plane of the tortuosity
was horizontal [10].
The results obtained in our study are consistent
with the published literature. In our study we found that
the vertebral artery had tortuous course in 18 (45%) cases.
A relatively high incidence of tortuosity of the vertebral
arteries could be explained with the mean age of our
patients. There was a high statistically significant
difference between the subjects with and without
tortuosity according to age (p<0.01). A suggested
congenital origin is difficult to be assessed since tortuosity
has been shown to increase with age.
Clinically, tortuosity of the V1 segment does not
have a hemodynamically significant consequence. The
presence of a tortuous vertebral artery may go undetected
because of the lack of symptoms. However, loops of the
vessel have been described to cause several problems.
Loops of the V1 segment have been reported to cause
radicular symptoms via nerve root compression. Vertebral
artery loop formation is one of those infrequent causes
which can cause pressure erosion of the adjacent vertebral
body, widening of the intervertebral foramen and compress
the cervical nerve root causing cervical radiculopathy.
Cervicobrachial neuralgia produced by vascular
compression presents with paraesthesia and dysaesthesia
of the fingers without a triggering factor, the lack of
nocturnal symptoms, and the rarity of neurologic deficits.
Symptomatic loops may be corrected by a bypass
procedure [2, 4, 5, 6, 7, 8, 9, 11].
Cervical spinal fracture has been reported
secondary to bony erosion from a V1 loop in contact.
Also, a vertebral loop caused by displacement from a mass
lesion in the scalenovertebral trigone may be compressed
and lead to vertebrobasilar insufficiency. Angiographic
or sonographic description of vertebral artery tortuosity
in patients with signs and symptoms of vertebrobasilar
insufficiency has led to surgical correction [2, 4].
When a tortuous vertebral artery is imaged,
clinical correlation is essential to determine whether the
Fig. 2.Tortuous course of the vertebral artery.
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abnormality is responsible for the patient’s signs and
symptoms. If a cause and effect are not clear, conservative
treatment is preferred. However, symptoms have been
relieved by surgical intervention in some cases when
radiculopathy was caused by nerve root compression due
to vascular anomaly [7].
The anterior approach for the decompression of
the cervical spinal cord and nerve roots with the anterior
interbody fusion is an accepted surgical treatment for
cervical radiculopathy. Although the reported results are
generally excellent, the procedure has some potential
complications, such as vertebral artery laceration [12].
In the presence of an abnormally tortuous
vertebral artery, using anatomic landmarks to guide
decompression may not prevent iatrogenic injury to the
vertebral artery. Failure to recognize this anomaly during
preoperative planning can lead to laceration of the vessel,
even when decompression is achieved within generally
accepted safe limits of lateral decompression [14]. The
potentially devastating complications of vertebral artery
injury with its supply of the cerebellum, brainstem and
spinal cord are well known: brain stem infarction and
central respiratory dysfunction [14].
From a surgical standpoint it can be of great
importance to know whether the vertebral artery is straight
or tortuous in, for example, surgical transposition of the
vertebral artery to the carotid artery because of high-grade
stenosis at its origin [2, 4].
Conclusion
In conclusion, we have presented an anatomical
study of the vertebral artery tortuosity. The authors
believe that proper and efficient demonstration and
evaluation of vertebral artery tortuosity will add important
contribution to the anatomic knowledge. Both vertebral
arteries showed a high incidence of tortuosity. Our study
has highlighted the possible role of vertebral artery
tortuosity in diagnostic and surgical procedures in order
to prevent vertebral artery injury.
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STATISTICAL   ANALYSIS  OF   THE   AVERAGE   VOLUME   OF   KIDNEY   DURING  FETAL   PERIOD   OF
GESTATION
Jovevska Svetlana, Matveeva N, Zafirova B, Bojadzieva B
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Abstract
Early antenatal diagnostics and importance of genetic consultation are of great interest for echosonographical
evaluation of normal fetus anatomy. This study was undertaken in order to analyze the anatomical growth and volume
of kidneys during their fetal development (from the IIIrd to  the Xth lunar month).  The research was carried out on
kidney of 300 fetuses of both sexes (154 males and 146 females).
 Macrodissection was used to extract both kidneys en block. The renal volume was measured by Vernier
caliper gauge and calculated from other kidney diameters using the ellipsoid formula:
Volume = length x width x thickness x ð/6.
The analysis of the average volume in the examined series of fetuses has shown statistically significant
differences in relation to the lunar month. Average volume of left fetal kidney in the IIIrd lunar month was 0.06 cm3 and
0.07 cm3 for the right kidney and continually increased up to 4,920 cm3 of  left and right kidneys in the Xth lunar month.
Key words: fetal kidney, volume, lunar months
Introduction
Renal congenital  abnormalities are not
uncommon in fetal life and they account for 30-40%.
Increasing importance of genetic consultation has great
interest for echosonographical evaluation of normal fetus
anatomy. By prenatal ultrasound one can find larger than
normal kidney  measurements in polycystic kidney, fetal
hydronephrosis etc., and smaller than normal in dysplasia,
hypoplasia, urethrocele etc (1,2,3). For some lethal
anomalies, like polycystic kidney, renal dysplasia, bilateral
renal agenesis etc., an early detection and termination of
the pregnancy may be a better choice. Identification of
either one or two kidneys by the ultrasound is possible in
90% of cases from the 17th until 22nd week of gestation,
and that is the critical time for genetic consultation.  After
the 20th week, the kidneys are identified in 95% of cases
(4). Unfortunately, diagnosis of renal abnormalities
appears relatively late in fetal life or postinatally.
Nowadays, ultrasonography is used as the modality of
choice for measuring a kidney size.
This study was conducted at the Institute of
Anatomy, Medical Faculty, Skopje. A total of 300 fetuses
were included, as follows:
* premature born and stillborn fetuses with
gestational age between IV-X lunar months, in 260 pairs
of kidneys “en block”;
* artificial abortions in the IIIrd lunar month and
40 pairs of kidneys “en block”, obtained from the
University Clinic of Gynecology and Obstetrics in Skopje.
Fetal kidneys were grouped according to
gestational age and location, left or right kidney. Fetuses
with malformations were excluded from the study.
Macrodissection was used to extract both kidneys “en
block” and they were separated from the surrounding
tissue. The renal volume was measured by Vernier caliper
and calculated from other kidney diameters using the
ellipsoid formula:
Volume = length x width x thickness x ð/6.
All data of interest for this study were proper
ordered and statistically analyzed using the following
statistical methods:
testing the significance of the difference between
three and several arithmetic means was done both with
the analysis of variance (ANOVA) and with Tukey’s
Honestly Significant Difference (HSD) test;
testing the significance of the difference between
two arithmetic means was done with the Student’s t-tesi.
Data are presented in tables and graphs.
Results
For realization of the aim of the study, a total of
300 fetuses with gestational age from the IIIrd to Xth lunar
month were analyzed. Of these, 146 (48.7%) were female
and 154 (51.3%) male fetuses. Fetal growth and
development of the kidneys (left and right) was monitored
by  measuring the volume in all kidneys in each lunar
month.
Material and Methods
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Table 1. Mean values in cm3 of left kidney volume in the
examined fetuses according to lunar months. [Analysis
of variance (ANOVA)].
Lunar N Mean values ±SD
month of volume of
left kidney (cm3)
III 40 0.007 0.005
IV 34 0.104 0.070
V 42 0.407 0.107
VI 52 1.538 0.453
VII 28 2.224 0.114
VIII 60 2.850 0.162
IX 27 3.331 0.131
X 17 4.920 0.458
Fig. 1. Mean values in cm3 of left kidney volume in the
examined fetuses aaccording to lunar months.
Table 1a. Significance of difference between mean values
of left kidney volume according to lunar months. (Tukey’s
Honestly Significant Difference (HSD) test).
Lunar month tukey (HSD) test p
III  -  IV 0.86759
IV  -  V 0.00003*
V  -  VI 0.00003*
VI  -  VII 0.00003*
VII  -  VIII 0.00003*
VIII  -  IX 0.00004*
IX  -  X 0.00003*
  * statistically significant differences
Table 2. Mean values in cm3 of right kidney volume in the
examined fetuses according to lunar months. [Analysis
of variance (ANOVA)].
Lunar N           Mean values                        ±SD
month              of volume of
              right kidney (cm³)
III 40 0.006                                0.004
IV 34 0.104                                0.069
V 42 0.499                                0.050
VI 52 1.541                                0.451
VII 28 2.223                                0.115
VIII 60 2.850                                0.162
IX 27 3.331                                0.131
X 17 4.920                                0.461
Fig. 2. Mean values in cm3 of right kidney volume in the
examined fetuses according to lunar months.
Table 2a. Significance of difference between mean values
of right kidney volume according to lunar months.
(Tukey’s Honestly Significant Difference (HSD) test).
Lunar month tukey (HSD) test p
III  -  IV 0.85287
IV  -  V 0.00003*
V  -  VI 0.00003*
VI  -  VII 0.00003*
VII  -  VIII 0.00003*
VIII  -  IX 0.00003*
IX  -  X 0.00003*
 * statistically significant differences
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The analysis of variance (ANOVA) has shown a
statistically significant differences between the mean
values of the left kidney volume in correlation with the
lunar months ( F = 10105,99 p = 0,0001 ) (Table 1 and Fig.
1).
Tukey honest significant difference (HSD) test
has shown the differences between the mean values of
the left kidney length in the examined fetuses in the
correlation to all examined lunar months separately. The
volume of the  left kidney significantly increased from
one to the next lunar month and all differences were
statistically significant. (Table 1a).
Table 2 and Fig. 2 present the mean values of the
right kidney volume in all 300 fetuses according to lunar
month.
The analysis of variance (ANOVA) has shown
statistically significant differences between the mean
values of the right kidney volume in correlation with the
lunar months (F = 10011,04        p = 0,0001 ).
Tukey honest significant difference (HSD) test
has shown the differences between the mean values of
the right kidney length in the examined fetuses in
correlation to all examined lunar months separately. The
volume of the  right kidney significantly increased from
one to the next lunar month and all differences were
statistically significant. (Table 2a).
Student’s t-test has shown that in the IIIrd and
IVth lunar month there were statistically significant
differences between male and female fetuses in correlation
to the volume of left kidney (female fetuses` volume of
left kidney is statistically bigger). In all other lunar month
the observed differences between the left and right kidney
of the examined fetuses were no significant).
Average volume of left fetal kidney in the IIIrd
lunar month was 0.06 cm3 and 0.07 cm3 of the right kidney
and continually increased up to 4,920 cm3 for both kidneys
in the Xth lunar month.
Discussion
To accomplish the aim of this study, we compared
the results obtained with the existing knowledge about
this issue found in the available literature. Development
of the human fetal kidneys goes through a series of
continual and mutually dependent anatomical changes
during which the kidneys obtain their morphological and
functional maturity. Growth and development of the fetal
kidney have been of interest to many scientists and
researchers (1, 3, 5, 7). In our study we determined the
volume of the fetal kidneys by measuring its dimension in
the three axes using the ellipsoid forumula. Many authors
determined the volume of a child’s kidney by measuring
its dimension in the three axes and using the ellipsoid
formula (5,6,7).
In our study the average volume of left fetal
kidney in the IIIrd lunar month was 0.06 cm3 and 0.07 cm3
of the right kidney and continually increased up to 4,920
cm3 for left and right kidneys in the Xth lunar month.
However, in the study of Slobodan Vlajkovic (8) the
average volume of fetal kidney continually increased from
0.33 cm³ in the IVth lunar month up to 8.68 cm³  (left kidney)
and 9.53cm³ (right kidney) in the Xth lunar month. Kidney
showed statistically significant (p<0,05) increase of volume
in the IVth lunar month and VIth lunar month.
The conclusion of Sampaio (5) that male fetuses
presented kidney volumes significantly greater than
female fetuses (found in 145 pairs of kidneys) is not in
accordance with our results where statistically significant
difference in kidney volume between male and female
fetuses during whole intrauterine life was not found. The
ratio: sum of volumes of both kidneys/crown-rump length,
Table 3. Significance of difference between mean values of the volume of the left and right kidneys according to lunar
months
Lunar months Left kidney Right kidney Student – t test  p
Mean values (cm³)  ±SD Mean values (cm³)  ±SD
III                           0.007 0.005 0.006 0.004 1.0
IV 0.104 0.070 0.104                     0.069                      1.0
V 0.407                     0.107 0.499 0.050 0.0067*
VI 1.538 0.453 1.541 0.451 0.9352
VII 2.224 0.114                     2.223 0.115 0.9149
VIII 2.850 0.162 2.850 0.162 1.0
IX 3.331 0.131 3.331 0.131 1.0
X                            4.920 0.458 4.920 0.461 0.9489
* statistically significant differences
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in absence of other better data, shows, in a specific way,
the quantity of kidney tissue per unit of fetus largeness.
The ratio increases with fetal aging, except in the second
half of the Vth lunar month when it stagnates. This ratio
displays the highest value in the Xth lunar month, when it
clearly shows that kidney is physically prepared for full
taking over of all its functions after birth.
Average volume of the left fetal kidney in the
IIIrd lunar month was 0.06 cm3 and 0.07 cm3 of the right
kidney and continually increased up to 4,920 cm3 for both
kidneys in the Xth lunar month.
Conclusion
The analysis of the average volume in the
examined series of fetuses has shown statistically
significant differences in relation to the lunar month.
Average volume of the left fetal kidney in the III lunar
month was 0.06 cm3 and 0.07 cm3 of the right kidney and
continually increased up to 4,920 cm3 for both kidneys in
the Xth lunar month. Measuring of kidney size can help in
determination of gestational age, especially in cases where
the date of the mother’s last menstruation is unknown.
7. Zalel Y, Lotan D, Achiron R et al. The early
development of the fetal kidney - an in
uterosonographic evaluation between 13 and 22
weeks gestation. Prenat Diagn 2002; 22:962-965
8. Slobodan Vlajkovic, Marija Dakovic – Bjelakovic,
Rade Cukuranovic et al.  The average volume of fetal
kidney during different periods of gestation. Acta
Medica Medianae 2005; 44 (2): 47-50
 References
1. Kurjak A, Zmijanac J. The anomalies of urinaru
system; in Kurjak A.(ed : Fetus as the Patiend (in
Croation). Zagreb, Naprijed, 1991 ; pp 199-209
2. Guillery EN. Fetal and neonatal nephrology. Curr Opin
Pediatr 1997; 9: 148-53.
3. Hsieh YY, Chang CC, Lee CC, Tsai HD, Fetal renal
volume assessment by three-dimensional
ultrasonography. Am J Obstet Gynecol 2000; 182 (2):
377-9.
4. Suranyi A, Nyari T, Pal A. What is biparietal diameter/
kidney length ratio in cases with renal
hyperchogenicity? Pediatr Nephrol 2003; 18: 14-7.
5. Sampaio FJ. Theoretical kidney volume versus real
kidney volume: coparative evaluation in fetuses. Surg
Radiol Anat 1995; 17(1): 71-5.
6. Vlajkovic S. Developmental anatomical characteristics
of the human fetal kidney [master’s thesis]. Nish:
School of Medicine; 1999
Jovevska S. Statistical  analysis  of  the  average  volume  of  kidney  during  fetal   period  of gestation
  26
THE  NEW  CLASSIFICATION  OF  DISTAL
EXTRAHEPATIC CHOLANGIOCARCINOMA-MORPHOLOGICAL
ANALYSIS AND REVIEW OF LITERATURE
Spasevska Liljana1, Dukova B1,  Janevski V2,
Shumkovski A2, Jankulovski N2
1
 Institute of Pathology, Faculty of Medicine, Skopje, R. Macedonia
2
 University Clinic of Abdominal Surgery, Faculty of Medicine, Skopje, R. Macedonia
Abstract
Extrahepatic cholangiocarcinoma (EH-CCa) is a malignant tumor that arises from the ductal epithelium of the
extrahepatic bile duct and it has been divided into perihilar and distal at the level of the cystic duct . As relatively rare
disease  perihilar and distal extrahepatic cholangiocarcinoma should be viewed as independent entities because of
their distinct biology and management.
The aim of the study was to make morphologic analysis of archive material of diagnosed EH-CCa at the
Institute of pathology, Medical Faculty, Skopje in 5-year period and revision of the cases according to 7th edition
(AJCC/UICC) TNM staging classification.
We used archive material from the data base of the Institute of pathology, Medical Faculty, Skopje, for 7 cases
diagnosed as distal EH-CCA between year 2006 and year 2010.
Four analyzed adenocarcinomas showed periductal-infiltrating pattern of growth and 3 cases had mass-
forming characteristics. One case revealed pancreatic involvement, 5 infiltrated the periductal soft tissue and 1 was
confined to the ductal wall. In 3 cases peri/intraneural invasion was found and 2 cases had vascular tumor embolusses.
There were 2 lymph nodes with metastases from 10 examined in only one case, in two cases there was no surgical
resection of lymph nodes, and the rest cases were free from metastatic disease. Positive surgical margines we found in
2 cases and 2 were negative. The most of EH-CCA were diagnosed in stage IB, one was in stage IA and one in stage IIB.
The purpose of  7th edition AJCC/UICC TNM staging system is predominantly prognostic and will require
additional validation.
Keywords: Extrahepatic cholangiocarcinoma, Distal bile duct carcinoma , Staging
Scheme 1. Location of bile duct cancers
Introduction
An extrahepatic cholangiocarcinoma (EH-CCa)
is a malignant tumor that arises from the ductal epithelium
of the extrahepatic bile duct and is the most common
primary malignancy of the biliary tract. However,
cholangiocarcinoma is relatively rare disease, accounting
for <2% of all human malignancies. Classically, extrahepatic
cholangiocarcinoma has been divided into perihilar and
distal extrahepatic cholangiocarcinoma at the level of the
cystic duct (Scheme 1). About  60-70% of EH-CCa arise at
Acta morphol. 2011; Vol.8(2):26-29
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the hepatic hilum, 20-30% arising from the distal common
bile duct while 5-10% of the tumors may be multifocal. [1,
2]
Perihilar and distal extrahepatic
cholangiocarcinoma should be viewed as independent
entities because of their distinct biology and management.
[1]
Distal extrahepatic cholangiocarcinomas are
defined as growing along the common bile duct between
the cystic duct and the ampulla of Vater and they are clearly
separated from ampullary carcinomas. Histologicaly they
are predominantly well-to-moderately differentiated
adenocarcinoma. The latest WHO classification, proposes
mass-forming, periductal-infiltrating lesion and intraductal
macroscopically growing type.  EH-CCa is difficult to
diagnose due to its silent clinical character, growth
patterns, anatomic location, the
low specificity of most diagnostic modalities and lack of
definite diagnostic criteria. Most patients present with
advanced disease that is not amenable to surgical
treatment. The median survival time for these patients
varies from 12-24 months.
Identification of the tumor stage and allocation
to the optimal treatment approach is important for this
aggressive carcinoma. Inaccurate staging can result in
inappropriate selection of a treatment option that either
deprives patients of a potentially curative procedure or
exposes them to unnecessary morbidity and mortality. The
7th edition American Cancer Committee/Union for
International Cancer Control (AJCC/UICC) TNM staging
classification (2010) is the first classification system that
has assignated a separated staging system for distal
extrahepatic cholangiocarcinoma.  [1, 2]
Aim of the study
The aim of the study was to make morphologic
analysis of archive material of diagnosed EH-CCa at
Institute of pathology, Medical Faculty, Skopje in 5-year
period and revision of the cases according to 7th edition
(AJCC/UICC) TNM staging classification (2010).
Methods
We used archive material from the data base of
the Institute of pathology, Medical Faculty, Skopje, for 7
cases diagnosed as distal EH-CCA between the year 2006
and 2010. Four were females and 3 were males, mean age
50,3 (ranges 48-60) for men and 60 (ranges 54-67) for
women. The performed analysis of the cases was
according to tumor growth pattern, histologic type,
pancreatic involvement, neural and vascular invasion,
surgical margines, lymph nodes metastasis and stage.
Results
The analysis confirmed that all of the cases were
adenocarcinomas, 4 of which showed periductal-
infiltrating pattern of growth (Figure 1.) and 3 cases had
mass-forming characteristics (Figure 2.). All cases showed
moderate differentiation, four of which presenting
desmoplastic reaction. One case revealed pancreatic tissue
Fig. 1. Periductal-infiltrative growth pattern (H.Ex40)
Fig. 2. Mass-forming growth pattern (H.Ex40)
Fig. 3. Perineural and intraneural invasion (H.Ex40)
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involvement, 5 of them were infiltrating the periductal soft
tissue and 1 was confined to the ductal wall. In 3 cases
peri/intraneural invasion was found (Figure 3.) and 2 had
vascular tumor embolusses (Figure 4.). There were 2 lymph
nodes with metastases (Figure 5.) from 10 examined in
only one case, in two cases there was no surgical resection
of lymph nodes and the rest cases were free from
metastatic disease.
Positive surgical margines we found in 2 cases
and 2 were negative.The analyzed tissues in 3 cases were
small resected fragments, so the evaluation of margins
was difficult. The most of EH-CCA were diagnosed in
stage IB, one was in stage IA and one in stage IIB (Table
1).
Discussion
Extrahepatic cholangiocarcinoma is a
devastating malignancy with an increasing incidence. It
is difficult to diagnose and frequently presents itself at a
late stage, mostly infiltrating the periductal soft tissue as
in our study. There is growing acceptance that EH-CCa
shoud be treated differently according to their location.
The updated 7th edition AJCC/UICC TNM staging
classification (2010) is the first classification system that
has assignated a separate staging system for distal
extrahepatic cholangiocarcinoma. This is an important
correction as perihilar and distal extrahepatic
cholangiocarcinoma differ in their presentation , natural
history, management and molecular signature [1, 2]. For
example, lymph node metastatic spread differs between
the two types of cholangiocarcinoma and is most
commonly observed in distal EH-CCa [3]. It is possible
that the observed difference in the rate of regional nodal
spread may represent a difference in nodal resection due
the anatomic limitations of portal node dissection and
pathologic assessment [4].
Murakami,Y et al. (2007) and Yoshida.T et al. (2002)
have suggested that number of lymph nodes is an
Fig. 4. Vascular tumor embolus (H.Ex40)
Fig. 5. Lymph node metastasis (H.Ex40)
year 2006 2007 2008 2009 2010
No of cases 1 1 1 1                                                    3
histologic  gradus G2  G2 G2 G2 G2        G2 G2
growth pattern mass-  mass-               periductal-       periductal-       periductal-               periductal-       mass-
forming      forming           infiltrative infiltrative       infiltrative               infiltrative    forming
spread                                 periductal    pancreas,          periductal confined to     periductal                   periductal      periductal
                                            soft tissue,   T2                    soft tissue, ductal wall,      soft tissue,                 soft tissue,     soft tissue,
T2                                      T2                  T1                  T2                             T2                T2
peri/intra neural invasion / yes / / yes / yes
vascular invasion / / yes / no / yes
(positive/isolated) 0/1 / 0/2 0/6 0/4 / 2/10
surgical margines R1 / R1 / R0 / R0
stage* IB IB IB IA IB IB IIB
* 7th edition (AJCC/UICC) TNM staging classification (2010)
Table 1. Morphologic analysis of distal extrahepatic cholangiocarcinoma in 5-year period
lymph nodes
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independent prognostic factor; and more than two
metastatic lymph nodes is predictive of worse outcomes
[5, 6]. The depth of tumor  invasion: confined to the bile
duct versus beyond it, or pancreatic invasion-
distinguishes by T1 and T2 stage is frequently criticized.
[7]. T stages were not found to be predictors of outcomes
after resection of these cancers, which indicates that the
definition needs to be more precise. Hong S.M. et al (2009)
grouped cancers into three groups according to their
invasion depth: < 5 mm, 5-12 mm and > 12 mm. They found
that this stratification is the strongest predictor for
outcome [8]. Most of our cases were classified as T2 (86%).
Redifinition of the T stages is also a step in the revision:
T4 describing invasion in the celiac axis and superior
mesenteric artery and T3 describing invasion of adjacent
organs but without invasion of arterial structures. The
prior AJCC/UICC distinguished T3 and T4 based upon
invasion of different organs; however, it was shown that
this definition of T3 and T4 was not able to distinguish
prognosis [9]. For distal extrahepatic
cholangiocarcinoma, perineural and microscopic vascular
invasion as well as  negative surgical margines were found
to be significant predictors of survival [7, 8,10,11]. The
prognostic  significance of location within the distal duct
appears to be most associated with the ability to resect
the lesion and obtain negative margins. After curative
resection, tumor free margins can be obtained in about
50% of distal tumor [12]. Our analysis revealed 28% of
cases with free surgical margins. According Sakamoto. Y
et al (2007) age, gender, tumor histology and histologic
grading were not found to be statistically prognostic
factors [7].
Conclusion
In summary the purpose of the 7th edition AJCC/
UICC TNM staging system is predominantly prognostic
and it will require additional validation. A staging system
providing treatment guidance has not been developed
and is needed.
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Abstract
Multicolor immunofluorescent labeling techniques are used for analysis of co-localization of antigens not
only in the same cell, but also in the same cellular compartment.
Objective of this study was to determine the localization of different antigens in a single frozen tissue section.
We present a method of multiple sequential immunofluorescent labeling in renal frozen tissue specimens. For
that purpose, we used unlabeled primary antibodies against CD133 and Cytokeratin, fluorochrome labeled secondary
antibodies and DAPI as nuclear counterstaining.
The immunofluorescent co-localization study showed that CD133 was localized mainly in the cells of the
Bowman capsule, in very few tubular segments in the vicinity of the glomeruli, as well as in the medullary tubular
segments.
Key words: multiple immunofluorescent labeling, frozen tissue, antigen co-localization
Introduction
Immunofluorecence has been introduced in the
cell biology investigations in the early 1940s when Albert
Coons et al. published the method of labeling antibodies
with fluorescent dyes (1). Since then, and especially by
the turn of the twenty-first century, the method of
fluorescent labeling has evolved and its use in the cell
biology investigations has become the cause for a
revolution in cellular and subcellular imaging.
The idea and necessity of simultaneous
visualization of two or more different antigens in the same
tissue section, the same cell, or even in the same cell
compartment has been challenging researchers since the
invention of the immunolabeling method.
The discoveries in many different scientific fields
have made the method of multiple immunostaining
possible and very valuable for the research work in the
cell biology. The synthesis of DAPI (4',6-diamidino-2-
phenylindole) in 1971 as a drug for trypanosomiasis, and
the discovery in the mid-seventies of the twentieth century
of its ability to form fluorescent complexes when bound
to DNA (2), was one of them. In addition, the introduction
of new fluorescent labels (3), as well as a variety of filter
sets for immunofluorescent microscopes, have made their
identification possible (4, 5), and the introduction of CCD
camera for a high-resolution analysis of biological
structures (6) has allowed sophisticated computational
image processing and analysis by commercial image
analysing software.
Methods for simultaneous detection of triple (7),
quadruple (8), and multiple - up to seven (9)  antigens
have been described in this paper.
Objective
The objective of this paper is to present the
method of double immunofluorescence staining in
determination of the localization of different antigens
(CD133 and Cytokeratin ) in a single renal frozen tissue
section, and the comparison of the results to those from
of immunohistochemical stainings.
Material
We used 20 renal biopsy samples obtained in
PBS, frozen in liquid nitrogen and stored at a temperature
of -80oC until the analysis. Only those diagnosed as
primary glomerulopathy with standard histological and
immunofluorescent examination were selected for double
immunofluorescent stainings.
As control, we used a tissue from normal adult
kidneys obtained for analysis for renal carcinoma which
did not affect the surrounding renal parenchyma.
Methods
Reagents
We used mouse monoclonal anti-human primary
antibodies against CD133 (clone AC133, dilution 1:10,
Miltenyi Biotec, Germany) and against Cytokeratin (clone
AE1/AE3, dilution 1:50, Dako, Denmark), and anti-mouse
secondary antibodies conjugated with fluorochromes
FITC (fluorescein isothiocyanat, emitting green signal
when excited at ~460 nm, with peak emission at ~520 nm),
and Cy3 (member of a family of synthetic fluorescent
cyanine dyes, excited at ~550 nm, with peak emission at
~570 nm, appearing red when seen under fluorescent
microscope). For counterstaining of the nuclei, we used
DAPI - (4',6-diamidino-2-phenylindole), which emits deep
blue signal under fluorescent microscope.
Preparation of tissue sections for storage
The frozen tissue was cut on a cryocut Leitz with
5µm thick sections and mounted on superfrost slides. The
sections were airdried for 30 minutes, fixed in cold acetone
for 10 minutes and again airdried for 30 minutes. Sections
were stored at -20oC until further usage. Before staining,
the slides were warmed at room temperature for 30 minutes
and washed in PBS 3 times for 5 minutes.
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Fluorescent double immunostaining
We performed a sequential staining method with
two primary antibodies raised in the same species. The
staining was performed at room temperature in a dark
humidified chamber.
The whole staining protocol can be divided into
the following steps:
1. First blocking step: in order to block unspecific
binding of the antibodies, the tissue sections are incubated
with 1% BSA in PBS for 30 minutes
2. First primary and secondary antibody: the
tissue sections are incubated with the first primary
antibody (CD133) diluted in 1% BSA in PBS for 1 hour,
followed by incubation with a first secondary antibody,
raised in the same species as the primary antibody
(mouse), labeled with fluorochrome Cy3 diluted in 1% BSA
in PBS for 45 minutes.
3. Washing with PBS 3x5 minutes is performed
between the incubation with primary and secondary
antibody, as well as after the first secondary antibody.
4. Second blocking step: incubation of the tissue
sections with 1% BSA in PBS for 30 minutes
5. Second primary and secondary antibody: the
tissue sections are incubated with the second primary
antibody (Cytokeratin) diluted in 1% BSA in PBS for 1
hour, followed by incubation with a second secondary
antibody raised in mouse, labeled with fluorochrome FITC
(which gives green fluorescent signal), diluted in 1% BSA
in PBS for 45 minutes.
6. Washing with PBS 3x5 minutes is performed
between the incubation with primary and secondary
antibody, as well as after the second secondary antibody.
7. Counterstaining of the nuclei with DAPI for 15
minutes.
8. The slides are mounted with anti-fade mounting
medium and stored at 4oC.
Immunohistochemistry
Immunohistochemical stainings were performed
both on frozen renal biopsy specimens and in control renal
tissue, by standard immunohistochemical procedure using
Dako EnVision vizualisation kit.
Controls
For positive control we stained frozen sections
from normal kidney applying the same immunofluorescent
method as described above, as well as
immunohistochemically with single antibodies.
Negative control stainings were done on control
sections of the same tissue placed on the same slides
with the analysed sections, by omitting the primary
antibodies during the staining procedure.
Fluorescence microscopy
Fluorescent microscope (Nikon Eclipse 1000)
with different optical filters for each fluorochrome and
CCD camera with software for image analysis was used
for collecting, digitizing, superimposing and storing
images. For FITC visualization, we used filter with
excitation wavelength between 450 and 490 nm and
emission wavelength 510 - 540 nm, for Cy3 filter with
excitation range between 510 and 560 nm and emission
wavelength between 570 and 590 nm, and the filter for
DAPI with excitation wavelength of 350 nm and emission
wavelength of 470 nm.
Images of the same view field seen with different
filters were acquired and digitally merged in order to
compare and see the overlap of the signals.
Results
On the fluorescent microscopy with appropriate
filters, the CD133 positive cells were marked with bright
red signal (Fig 1a and 1b), the Cytokeratin positive cells
were marked with bright green signal (Fig. 2a and 2b) and
the nuclei appeared deep blue (Fig.3).
The merged images showed their co-localization.
Namely, the CD133+/Cytokeratin+ (Fig. 4a and 4b) cells
appeared orange due to the superimposed colors and were
found in some of the tubules close to the glomeruli and in
many medullary tubular segments. Interestingly, the
CD133+ cells in the Bowman capsule showed only a weak
signal for Cytokeratin. Furthermore, the analysis revealed
some non-epithelial cells positive for CD133 in the fibrotic
interstitium between atrophic tubuli.
The same distribution of positive signal for CD133
was found on the immunohistochemical stainings with
single antibodies.
Discussion
Immunofluorescence is a common laboratory
technique with a broad spectrum of application in biology,
both for research and for routine analyses. There are two
basic immunofluorescent methods such as the direct
labeling (where the antibody is conjugated to a fluorescent
dye – fluorochrome) and the indirect labeling (where the
primary antibody is unconjugated and the secondary
antibody, which amplifies the signal, is labeled with a
fluorochrome).
In histopathology practice, these analyses can
be performed in fresh and in fixed tissue samples (10),
both of which have advantages and disadvantages.
There are plenty of advantages of
immunofluorescent staining techniques performed on
frozen tissue are many: shorter time of tissue processing,
better preservation of the antigenic content, less
autofluorescence than in paraffin embedded tissue, while
the paraffin embedded tissue takes longer time to prepare,
sometimes needs antigen retrieval technique, but gives
much better tissue and cell morphology. On the other hand,
the obtained staining signal is permanent in the paraffin
embedded tissue and fading in time in frozen tissue
specimens.
Both immunofluorescence and
immunohistochemical techniques can be used for multiple
labeling and co-localization studies. However,
immunohistochemistry is better applicable for antigens
located in different tissue segments (11), where the single
colors can be easily be appreciated and distinguished from
each other. On the contrary, if the targets are co-localized
within the same cell, the effect of the mixture of both colors
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Fig. 1a. CD133 positive cells in cortical area - Bowman
capsule and in the vicinity of the glomerulus (x20)
Fig. 1b. CD133 positive cells in medullary tubular segments
(x20)
Fig. 2a. Cytokeratin positive cells in the cortical area (x20) Fig. 2b. Cytokeratin positive cells in medullary tubular
segments (x20)
Fig. 3. DAPI positive nuclei (x20)
Fig. 4a. Merged image showing CD133+/Cytokeratin+ cells
in the cortical area (x20)
Fig. 4b. Merged image showing CD133+/Cytokeratin+ cells
in the medullary area (x20)
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creates interpretation difficulties and can be easily
misinterpreted if one of the colors overwhelms the other
(12), the cells are tightly packed or have only scant
cytoplasm, like lymphocytes (13).
The method of double immunofluorescent
labeling has the advantage of digital image analysis where
each fluorescent dye is separately viewed and stored, and
the acquired images are digitally merged (14).
Consequently, this method enables better determination
of intracellular co-localization, but lacks the possibility of
deeper morphological analysis.
There are two basic approaches to multiple
fluorescent immunolabeling the simultaneous and
sequential approach. During the simultaneous method,
the tissue is first incubated with a mixture of two different
primary antibodies, and then with mixture of appropriate
two different secondary antibodies. In order to avoid
cross-reactivity, this method requires the used primary
antibodies, as well as the appropriate secondary
antibodies, to be  raised in different species (e.g.,
combination mouse-rabbit, mouse-goat, etc.).
We present a sequential method of step-by-step
incubation with a single primary antibody, which is
followed by incubation with appropriate single secondary
antibody, a procedure which is repeated with the second
primary and secondary antibody. The advantage of this
method is that both primary antibodies (and thus, the
appropriate secondary antibodies, too) can be raised in
the same species. During this method, in order to avoid
unspecific binding of the antibodies, the first step is
blocking by incubation with 1% BSA, or alternatively, with
10% serum from the species in which the secondary
antibody was raised in, followed by thorough washing
with low pH buffer is performed between each step in
order to remove the immunoreagents from the previous
staining sequence and prevent cross-reactivity (15).
Control experiments are necessary for safe interpretation
of results obtained with this type of double staining.  The
so called “Half-double staining” experiment has also been
proposed, i.e. omitting the primary antibodies (12).
Another control for the quality of the method is the
comparison to the single stained slides. We have chosen
to do this control with the immunohistochemical method
applying the same antibodies, in order to visualize the
surrounding tissue components and total tissue
morphology, which otherwise can not be appreciated on
the dark field microscopy.
CD133 is a transmembrane glycoprotein
selectively expressed on populations of hematopoietic
stem and progenitor cells, on stem cells in a variety of
adult non-hematopoietic tissues (kidney, prostatic
epithelia, muscle tissue, liver and cornea), on cancer stem
cells of a variety of cellular and tissue origin, as well as in
human fetal tissue (brain, skin, neural tube, gut, kidney
and liver).
Cytokeratin is a protein of keratin-containing
intermediate filaments in the cytoskeleton of the epithelial
cells, and is therefore used for their identification in normal
tissue and for detection of origin of cancer tissue.
The presented study and the evident co-
localization of these two antibodies in certain resident
kidney cells encourages further analysis with a broader
panel of antibodies in order to identify the stem cells and
determine the sites of their localization in normal and
pathologically altered kidney tissue.
In conclusion, the method of double
immunofluorescent labeling is a valuable and mighty tool
in the researcher‘s hands, but only when planned
thoroughly and used with proper controls. Therefore the
combination of antibodies must be well studied and
planned in order to avoid cross-reactivity, controls must
be included, and ancillary analyses of tissue morphology
must be  performed as well.
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Abstract
Medullary thyroid carcinomas (MTCs) are rare neoplasms comprising not more than 2-10% of all thyroid
malignancies. It has been noted that some MTC cases present an indolent, and some, an aggressive clinical course. We
re-evaluated archive specimens from 20 cases of MTCs and performed additional immunostainigs with anti-Ki-67 and
anti-Bcl-2 antibodies. The re-evaluation included: histological subtype, type of tumor margin (expansive or infiltrative),
expression of Bcl-2 and Ki-67. We also analyzed the age and sex distribution, tumor greatest diameter, presence of
regional lymph node and/or distant metastases at the time of operation, the stage of the disease, and the clinical history
of the patients. According to the clinical parameters, patients had been clinically divided into two groups designated
as “group 1” - indolent disease course and “group 2” - aggressive disease course. The ethnical ratio of macedonian vs.
non-macedonian patients (70:30) is quite similar to the overall ratio in the general population, suggesting absence of
specific ethnicity-related factors influencing the incidence of MTC in our population. Most of the patients (n = 11)
were in stage II by the time of operation, and the mean tumor diameter at operation was 4,2 cm. Tumor histotype was not
correlated to the investigated parameters. Ki-67 expression was low (6,55%). We found significantly higher Ki-67
expression in women, compared to men (p <0,05). This difference had no influence on the disease course, and there
were no correlations to the other parameters. Bcl-2 expression was high (68,3% of tumor cells), with no male:female
differences, neither correlations to other investigated parameters. The aggressiveness of the disease was correlated to
the type of tumor growth, regional lymph node status and the stage of the disease at operation. The infiltrative type of
tumor margin was correlated to more aggressive clinical course, compared to the expansive type of tumor margin
(p<0,05).
Key words:Medullary thyroid carcinoma, histopype frequency, Ki-67, Bcl-2
Introduction
Medullary thyroid carcinomas (MTCs) are rare
neoplasms comprising not more than 2-10% of all thyroid
malignancies (1, 2). Most of them appear as sporadic (75-
80%), and the reminder are familial and MEN2 related cases
(1, 3, 4). According to the US National Cancer Institute
the incidence of MTCs in the US range between 500-1000
cases per year (in a population of 300 mil.), or 2-3% of all
thyroid cancers which incidence is 37300 cases per year.
According to the statistics from France and USA 43%
and 44% of MTCs, respectively, are familial cases, and
frequently associated with MEN2 syndrome, while in
Sweden, this percentage is much lower – around 26%.
According to the NCI estimations, the same percentage
should be applicable to Europe in general (2). Having in
mind the aforementioned proportions, data from the
Macedonian Institute for Public Health, the Institute of
Pathology and the Institute for Radiotherapy and
Oncology in Skopje, there should be 2-3 newly diagnosed
cases of MTC in Macedonia (population of approx. 2 mil.)
per year. However, in the last 15 years we have diagnosed
only 22 cases, and none of them was MEN2 related, neither
a case of Familial Medullary Thyroid Cancer (FMTC).
It has been noted that some MTC cases present
an indolent, and some an aggressive clinical course (1, 4,
5).
According to the WHO, 12 histologic variants
of MTC are recognized (Tab.1), although there are no exact
frequency data, neither data about possible population
Table 1 Variants of medullary thyroid cancer (modified from the WHO)
Variant Variant designation Histologic characteristics
Type 1 Papillary or psaudopapillary Presence of true papillae or artefactual pseudopapillae, caused by tissue
fragmentation
Type 2 Glandular (tubular or follicular) Presence of tubular or follicular structures lined with neoplastic cells
Type 3 Giant cell
Type 4 Spindle cell
Type 5 Small cell and neuroblastoma-like
Type 6 Paraganglioma like
Type 7 Oncocytic cell
Type 8 Clear cell
Type 9 Angiosarcoma-like
Type 10 Squamous cell
Type 11 Melanin-producing
Type 12 Amphicrine
Acta morphol. 2011; Vol.8(2): 35-42
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related differences, nor data about the correlation of the
specific histotypes with the clinical behaviour of the
tumors. In general, addressing the issue of Ki-67 there are
reports about very low Ki-67 expression in all MTCs (6),
with documented exeptions (7), whereas for the Bcl-2, high
expressions have been reported in majority of the cases,
and some studies have shown that Bcl-2 expression has a
positive prognostic value (8).
Aims
To evaluate the clinical and pathohistological
features of MTCs arising in Macedonian population,
primarily the histotypes of the tumors, possible different
expression patterns for Ki-67 and Bcl-2, and their
correlation to the clinical behavior of the tumors.
Material and Methods
We re-evaluated retrospectively archive
specimens from 20 cases of MTCs on standard HeEo
stainings, and performed additional immunostainigs
(LSAB+, DAKO) with anti-Ki-67 antibody (clone MIB-1)
and anti-Bcl-2 antibody (clone 124) both from DAKO. The
dilution for the anti-Ki-67 antibody was 1:25, and for the
anti-Bcl-2 antibody 1:50. The microscopic re-evaluation
included the following parameters: the histological
subtype, the type of tumor margin (expansive or
infiltrative), as well as, expression of Bcl-2 and Ki-67.
Microscopic re-evaluation was performed by at least two
pathologists independently, and equivocal parameters
were solved with consensus. We also analysed the age
and sex distribution, tumor greatest diameter, presence of
regional lymph node and/or distant metastases at the time
of operation, and the stage of the disease. Furthermore,
we evaluated the clinical history of the cases using the
clinical data obtained from the University Clinic for
Thoracovascular Surgery, and the Institute for
Pathophysiology and Nuclear Medicine in Skopje.  We
included data for the elapsed time from onset of the first
symptoms/signs until the operation, time from the primary
operation until the eventual recurence and/or appearance
of local lymph node and/or distant metastases, family
history and presence of a possible MEN2 syndrome.
According to the clinical parameters (as mentioned
previously), patients had been clinically divided into two
groups designated as “group 1” containing patients with
indolent disease course and “group 2” consisted of
patients with aggresive disease course.
Results
Sixty percent of the patients were women, and
the mean age of the patients was 53,7 years with normal
age distribution (fig. 2) (min. 19; max. 76; med. 55,5; St.
dev. 14,3), with no significant age difference between men
(mean age 55,8) and women (mean age 52,2) (p>0,05) (Figs.
1-2).
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Fig. 2. Age distribution of the patients
According to the ethnicity, 70% of the patients
were macedonians, and 30% of non-macedonian
ethnicity (fig. 3).
Pie Chart (BazaTir.sta 26v*20c)
Ethnicity
non-maced., 30%
macedon., 70%
Fig. 3. Ethnical distribution of the patients
Eight of the patients had been clinically
designated in the first group, indolent/intermediate disease
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course (Gr. 1), while 12 of them had an aggressive disease
(Gr. 2). None of the patients  had FMTC or MEN2.
The mean tumor diameter at operation was 4,2
cm (Min 2,5 cm; Max. 9,0 cm; Med. 3,8 cm; St. dev 1,74).
There was no significant correlation between the tumor
diameter and the age of the patients (Spearman Rank Order
Correlation R=-0,02) (p>0,05), and we also did not find
any differences between the tumor diameter in females
vs. males (Mann-Whitney U Test U=41,0; Z=-0,084;
p>0,05) (Fig. 4).
Boxplot by Group
Variable: Dim.(cm)
 Median 
 25%-75% 
 Min-Max Female Male
Gender
2
3
4
5
6
7
8
9
10
D
im
.
(cm
)
Fig. 4. Tumor diameter in female and male patients
Eleven of the patients were in Stage II, 7 in
stage III, 2 in Stage IV, and there were no patients in
Stage I disease (Fig. 5).
Histogram: Stage
Stage II Stage III Stage IV
Stage (pTNM)
0
2
4
6
8
10
12
14
No
.
 
o
f o
bs
.
Fig. 5. Frequency table: Distribution according to the
disease stage
The stage was only correlated to the parameters
already comprised in it (i.e. pTNM parameters), and also
with the type of the tumor margin (R = 0,54; p<0,05),
although there was no direct correlation between the type
of the tumor margin and the tumor diameter, neither a
significant differences of the tumor diameter between
cases with infiltrative vs. expansive tumor margin (Fig. 6).
Boxplot by Group
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Mann-Whitney U Test: U = 40,5; Z = -0.29; p>0,05
Fig. 6. Mean diameter in tumors with expansive vs.
infiltrative tumor margin
According to the tumor histotype,  most of the
tumors were of “classical” (n = 6) and “spindle cell”
appearance or type 4 (n = 6), followed by “papillary/
pseudopapillary” – type 1, “small cell and Neuroblastoma-
like” - type 5, and “Paraganglioma-like” - type 6 variants –
all of them represented by 2 cases each, and the least
frequent were “Giant cell” - type 3 and “Angiosarcoma-
like” – type 9  tumors – represented by a single case each
(fig. 7, 8). The tumor histotype was not correlated to any
of the investigated parameters, neither had any significant
influence on the tumor behavior, regarding the
aggressiveness of the disease, or the stage of the disease.
Histogram: Histotype
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*See tab.1
Fig. 7. Frequency of observed tumor histotypes
For Bcl-2 expression we found that majority of
the tumors had high Bcl-2 expression, averaging 68,3% of
tumor cells (max. 95%; min. 1%; St.dev. 33,7). There was
no significant difference in Bcl-2 expression pattern
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between males and females (p>0,05) (fig. 8, 9). Bcl-2
expression was not correlated to any of the investigated
parameters, neither had any significant influence on the
tumor behavior, regarding the aggressiveness of the
disease.
Categ. Box & Whisker Plot:    Bcl2%
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Fig. 9. Bcl-2 expression in males and females
For Ki-67 we found that majority of the tumors
had low expression (fig. 8) with mean value of 6,55 % of
tumor cells (max. 30% , min. 0%; St. dev. 9,86). However,
there was a significant difference between males and
females for Ki-67 expression (p<0,05) with Ki-67 averaging
10,2% of tumor cells in females (max. 30%; min. 1%; St.dev.
11,5) and only 1,1% in males (max. 5%; min. 0%; St. dev.
1,24) (fig. 10). Ki-67 expression was not correlated to any
Fig. 8 Histotypes and staining patterns for Ki-67 and Bcl-2
other of the investigated parameters, neither had any
significant influence on the aggressiveness of the disease.
Box & Whisker Plot:    Ki67%
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T-test: 2,2; df = 18; p<0,05
Fig. 10. Ki-67 expression in males and females
In cases where metastases appeared after the
operation, during the follow up, the mean time for the
appearance of the nodal metastases was 38 months
(observed in 2 males and 2 females) (fig. 11), with three of
the cases presenting with regional lymph node
metastases, and one of the females with a liver metastasis.
One of the males and one of the females were in stage II
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(postoperative staging) and evolved into Stage IV with
the appearance of the metastases, and the other couple
shifted from stage III (postoperative staging) into Stage
IV (during follow up).
Valid N   Mean    Min         Max          Std.Dev.
t(m) to MS   4          38.00000 19.00000 51.00000   15.38397
*2 females and 2 males
Fig. 11. Time elapsed from operation until the appearance
of metastases.
Because of the low number of cases, we were
not able to perform any analytical statistics for this
parameter.
The attribute of aggressiveness was correlated
to the type of tumor growth, regional lymph node status
and the stage at operation  (fig. 12).
     Valid     Spearman t(N-2) p-level
Aggress. & Tu.growth       20 0.49     2.4 < 0.05
Aggress. & pN          20 0.70     4.2 < 0.01
Aggress. & Stage          20 0.79    5.53 < 0.01
Fig. 12. Parameters correlated to the disease
aggressiveness
We tested the significance of differences
between the aggressive disease cases and the indolent
ones for the above mentioned parameters (figs. 13-15).
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Fig. 13. Distribution of aggressive and indolent clinical
course cases in respect to the lymph node status at
operation.
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Fig. 14. Distribution of aggressive and indolent clinical
course cases in respect to the lymph node status at
operation.
Categorized Histogram: Agresiv. x Stage
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Distribution of Stage 2 vs.stage 3 patients according to
the agressiveness of the disease:
Chi-Square (df = 1) 11,45; p < 0,01
Fisher exact (one-tailed); p<0,01
Distribution of Stage 2 vs.stage 4 patients according to
the agressiveness of the disease:
Chi-Square (df = 1) 8,18; p < 0,01
Fisher exact (one-tailed); p<0,05
Fig. 15. Distribution of aggressive and indolent clinical
course cases in respect to the stage at operation.
We found that there was a significant difference
in case distribution according to the clinical behavior in
respect to the tumor growth, lymph node metastases and
the stage of the disease at operation. Six (of nine) of the
indolent cases presented with non-infiltrative growth
pattern in contrast to only 2 (of 11) of the “aggresive”
cases (p<0,05) (fig. 13). Most of the aggressive cases (n =
9) have already had lymph node metastases by the time of
operation, compared to only 1 of the “indolent clinical
course” cases (p<0,01) (fig. 14). Similar situation was
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observed in respect to the stage of the patients. All
indolent cases were still in stage II at operation, while in
the “aggressive” group only 2 patients were in stage II,
while most of them were in stage III (n = 7) and two were
in stage IV (fig. 15).
There was a rather peculiar phenomenon
concerning the ethnicity of the patients. We observed
significantly higher frequency of higher pT parameter in
non-macedonian ethnicity compared to the macedonian
patients who presented more frequently lower pT
parameter (p<0,05). Eleven of 14 macedonians had tumors
designated in pT2 category, but only 1 of 6 non-
macedonians had tumors designated in pT2 category, with
larger tumors (pT3) being found more frequently in non-
macedonian patients (fig. 16).
Categorized Histogram: Ethnicity x pT
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Yates Chi-square 4.375000; df = 1; p<0,05
Fig. 16. Tumor diameter (pT) in respect to the patients’
ethnicity.
However, ethnicity of the patients was not
directly correlated to none of the other investigated
parameters. Furthermore, we tested the differences in mean
tumor diameters in macedonian vs. non-macedonian
patients, and we came up with a non-significant difference.
The mean tumor diameter in macedonian patients was 3,68
(min. 2,5; max; 6,0; St. dev. 1,18), while in non-macedonian
patients the mean diameter was 5,28 (min. 2,7 max. 9,0; St.
dev. 2,34) p>0,05 (Fig. 16), suggesting a statistically biased
distribution of the pT parameter for the observed absolute
tumor diameters.
Box & Whisker Plot: Dim.(cm)
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t = -2,02; df = 17; p>0,05
Fig. 17. Mean tumor diameter (cm) in macedonian vs. non-
macedonian patients
Discussion
The age and gender distribution of the analyzed
group is in accordance to other previously published
analyses (4, 6) where slight female predominance has been
obseved, which in our case was 1:1,5 (male to female ratio),
and mean age 50, similar to our mean age of 53,7.
The ethnical ratio of macedonian vs. non-
macedonian patients (70:30) is quite similar to the overall
ratio in the general popullation (9), suggesting absence of
specific ethnicity-related factors influencing the incidence
of MTC in our population. We encountered quite
unexpected ratio between the cases presenting an indolent
disease course (n = 8) and those with an aggressive disease
course (n = 12), taking into consideration that indolent
disease course is expected in patients suffering from
FMTC and those with MEN2B syndrome (4, 5, 6), but not
so frequently in patients with sporadic MTC, as our
patients  actually were. We exclude the possibility of MEN2
since all of the patients have been checked thoroughly
for clinical and biochemical signs, although the possibility
stays that some of them could be in fact cases of FMTC
with poorely analysed disease - specific family history or
some of them have not given correct anamnestic data
(deliberately or  unvolountarily). This possibility goes
along with the fact that at least 20% od MTCs in Europe
are expected to be familial cases (1, 2, 3, 4, 6). Nevertheless,
these results suggest further, extended (at least
anamnestic) evaluation of the patients’ relatives and more
precise anamnestic re-evaluation of the patients, and
possibly  random ultrasound and/or biochemical
screening of the relatives of our younger patients – since
it has been shown that familial cases tend to appear
approximately 10 years earlier than sporadic do (2, 4, 6).
Having in mind that we were already missing at least 8
MTC patients (according to the incidence statistics for
Europe), there is another, rather unlikely possibility that
those missing cases would be FMTC cases with indolent
disease course that have remained unrecognnized or have
died of disease- unrelated cause before correct diagnosis
could have been established.
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Most of the patients (n = 11) were in stage II by the time of
operation, and the mean tumor diameter at operation was
4,2 cm (min 2,5 cm; max. 9,0 cm; med. 3,8 cm; St. dev 1,74),
which we consider a rather large tumor, although
comparable to other studies (6). However, it is quite
unsatisfactory that none of the patients had been operated
in stage I, although this could be easily explained by the
fact that none of the patients were actually aware of being
at an increased risk for MTC (i.e. positive familial history),
which is on the other hand closely dependent on our ability
to“recognize” such families.
The notion of the most prevalent histotypes of
MTC in our series (the classical and spindle cell type;
comprising for 60% of cases)  have merely a differential
diagnostic significance, since the histotype was not
correlated to none of the investigated parameters including
the clinical behaviour of the tumor. We also couldn’t find
any relevant data about the influence of the histologic
variants on the clinical course of the disease. The general
Ki-67 expression was low (6,55% of tumor cells ) as
expected and as published in other studies (6). However
in our series we encountered a rather odd phenomenon of
significantly higher Ki-67 expression in women (mean
10,2% of tumor cells) compared to men (mean 1,1% of
tumor cells)  (p <0,05). We have no plausible explanation
for this phenomenon, and we haven’t found similar
published results in the reviewed literature. However, this
difference had no influence on the disease course, and
there were no correlations to the other investigated
parameters. Maybe further studies about the influence of
sex hormones would provide a satisfactory explanation.
Opposite to the Ki-67 expression, which was generally
low, we found high Bcl-2 expression averaging 68,3% of
tumor cells, but with no significant male to female
differences, neither correlations to other investigated
parameters, including the disease course. Our data
generally correlate with the results from Cobanoglu et al.
and Viale et al. (7, 8) who also found high Bcl-2 expression.
However, our average Bcl-2 expression (68,3%) is lower
that that observed by Cobanoglu et al. who reported 90%
positivity. This discrepancy has emerged because we had
4 patients in our series with (extremely) low Bcl-2
expression (1%, 5%, 10% and 20% respectively). Viale et
al. found that 26 out of 33 MTC cases had Bcl-2 expression
in more than 25% of the cells. Although they have reported
longer survival in Bcl-2 positive cases, we were not able
to find any correlations between the Bcl-2 expression to
the clinical parameters. The aggressiveness of the disease
was correlated only to the type of tumor growth, regional
lymph node status and the stage of the disease at operation
(fig. 11). Since the stage of the disease includes the
regional lymph node status (as one of the pTNM
parameters), it is obvious that it can not be observed as
an independent predictor of the tumor aggressiveness.
However, the type of the tumor margin (infiltrative vs.
expansive) appears to be a distinct predictive factor for
the aggressive tumor behaviour (at least in our series).
This parameter has not been included in the prognostic
parameters by the WHO (6). The most similar parameter
recognized by the WHO as a predictive factor is the “extent
of the local tumor invasion”, which is clearly different
from the “type of the tumor margin” that we have analyzed.
As far as the aggressiveness of the disease is concerned,
there are a lot of studies (and controversy) dealing with
the influence of different ret proto-oncogene mutations
(1, 3, 6, 10), yet relatively few studies analyzing the
morphologic parameters that influence the disease course
(6, 11, 12). Many of the latest studies suggest genetic
testing for ret mutations in all cases of MTC, especially
when diagnosed in younger patients, and in cases of
suspected FMTC or MEN2 syndromes, thus lowering the
chances of having unrecognized familial cases, as  probably
happened in our series.
Conclusions
1. In the last 15 years there are fewer diagnosed MTCs
compared to the predicted incidence and the European
average.
2. In our series there are missing FMTC and/or MEN2
patients, that should have been diagnosed according
to the predictions based upon US and European
statistics.
3. Further analyses are needed to confirm or rule-out the
aforementioned statistical discrepancies, and probably
applying more detailed anamnestic questionaires,
ultrasound and/or biochemical screening at least of the
younger patients’ close relatives.
4. Genetic testing for ret mutations in MTC cases should
be taken into serious consideration having in mind the
latest trends, and the problems we are facing regarding
the FMTCs and MEN2-related MTCs.
5. The infiltrative type of tumor margin is correlated to
more aggressive clinical course, compared to the
expansive type of tumor margin (p<0,05).
6. Bcl-2 and Ki-67 immunohistochemical expressions are
not correlated to the clinical behaviour of MTC.
7. The most frequent MTC histologic variants in our
population are the “classical” and the “spindle cell
variant” comprising 60% of cases, followed by the
“Papillary/pseudopapillary”, “Small cell and
Neuroblastoma-like”, and ”Paraganglioma-like” variants
– 10% each; and the least frequent are the “Giant cell”
- and “Angiosarcoma-like” variants – 5% each.
8. Histologic variants of MTC are not correlated to the
clinical behaviour of the tumors, neither to the rest of
the invesigated parameters, but knowing them well is
probably important for solving differential diagnosis in
some cases.
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MORPHOLOGICAL    ABERRATIONS   OF THE  WIDTH   OF ATTACHED GINGIVA AND THEIR   INFLUENCE
Introduction
The width of attached gingiva is defined as the
distance between the mucogingival junction and the
projection on the external surface of the bottom of gingival
sulcus or the periodontal pocket. It is not synonymous
with keratinized gingiva because the latter also includes
the free gingival margin. The width of attached gingiva
varies in different individuals and on different teeth of the
same individual, but generally appears to be accepted as
an inevitable part of the aging process. Many adult
patients may have areas of a narrow band of attached
gingiva that are stable and do not require a specific
intervention. However, in some patients the same
condition may lead to exposure of an unacceptable
amount of root surface causing esthetic problems, dental
hypersensitivity, potential root caries, as well as
mucogingival problems.
Several studies have been undertaken to find
the relationship between amounts of attached gingiva, or
its absence and gingival inflammation.[1,2] An adequate
band of attached gingiva is considered that amount that
is sufficient to maintain periodontal health. [3,4]
The study by Lang and Löe (1972) regarding the
significance of an adequate zone of attached gingiva for
maintaining periodontal health concluded that 2 mm of
attached gingiva is adequate to maintain gingival health;
and this expression has been widely quoted as a definition
as to what constitutes an adequate width of gingiva for
the maintenance of periodontal health [1].
ON  GINGIVAL    HEALTH    AND   ATTACHMENT   LOST
 It is debatable that an adequate zone of attached
gingiva is an essential prerequisite to maintain periodontal
health. The validity of the assumption that the presence
of attached gingiva reduces the risk of further loss of
attachment appears to be questionable [5].
Therefore the main aim of our study was to
determine the influence, if any, of different widths of
attached gingiva on attachment loss.
Material and Methods
The survey was carried out on 209  lower incisor
due to extraction. The preextaction history was of no
significant interest for our study. Patients were selected
according to previously set criteria
-Age between 20-40 years of age
-no previous history of any disease or medications that
have been taken
-the teeth in the examined region should have no extensive
caries destruction or destruction that was under the
marginal gingiva.
– the teeth should have an intact cemento–enamel
junction, no dental restoration or caries extending beyond
cemento–enamel junction and there was no visible damage
from extraction procedure.
-patients with mucogingival aberrations such as high
frenulum insertion, and morphological abnormalities of
teeth such as root grooves, enamel pearl were excluded
from the study.
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Abstract
Since many years, a great number of studies have been discussing the role of attached gingiva in marginal
periodontal behavior, either accepting that a minimum of 2.0 mm of  width is required to maintain marginal periodontal
health or suggesting that width is negligible if excellent oral hygiene is performed, yet areas with narrow width of
attached gingiva seem to be prone to periodontal attachment loss. Therefore the main aim of our study was to
determine the influence, if any, of different widths of attached gingiva on attachment loss.
The survey was carried out on 209 lower incisor due to extraction.
Prior to extraction plague index, index of gingival bleeding upon probing, and gingival inflammation (Sillnes
Loe) were noted for each tooth. Afterwards the width of attached gingiva  in lower vestibule was measured.
After extraction the periodontally involved part of the root was carefully scaled and cleaned in running water
and then stained for 10 seconds in 0.1% toludine blue to facilitate the measurement of attachment loss. Loss of
attachment was then measured along the long axis of the tooth from cemento–enamel junction to the most coronal level
of the stained periodontal ligament on the vestibular, distal and lingual surface.
Obtained data were divided into two groups according to the previously measured width of attached gingiva.
-Group1 teeth extracted from regions with attached gingiva equal or more than 2 mm (n=115)
-Group2 teeth extracted from regions with attached gingiva less than 2 mm. (n=94)
Obtained data showed statistically significant higher values of plague and gingival indices for the second
group. Attachment loss was significantly higher in regions with inadequate width of attached gingiva.
Key words: attached gingiva, width, attachment loss, gingival inflammation.
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- Patients in the examined region did not have any
prosthetic appliances especially implants or crowns on
the examined teeth.
Prior to extraction plague index, index of gingival
bleeding upon probing, and gingival inflammation
according to criteria proposed by Sillnes  and Loe [6] were
noted for each tooth. Afterwards the width of attached
gingiva was measured.
After extraction the periodontally involved part
of the root was carefully scaled and cleaned in running
water and then stained for 10 seconds in 0.1% toludine
blue to facilitate the measurement of attachment loss. Loss
of attachment was then measured along the long axis of
the tooth from cemento–enamel junction to the most
coronal level of the stained periodontal ligament on the
vestibular, distal and lingual surface.
Obtained data were divided into two groups
according to the previously measured width of attached
gingiva.
-Group 1 consisted of 115 teeth extracted from regions
with attached gingiva equal or more 2 mm
-Group2 consisted of 94 teeth extracted from regions with
attached gingiva less than 2 mm.
Results were statistically processed using the
computer program Statistic 6. Mean value of the measured
attached gingiva, and attachment lost was calculated for
both groups. Significance of difference of values for the
gingival indices and attachment lost between both groups
was tested by student t test.
Results
The examined group was formed of 138 male and
71 female (total 209) patients with mean age of 32, 2 years.
Results for the mean value for the width of attached
gingiva for each group were;
Table 1. Plaque and gingival index values for Group 1(width of attached gingiva more than 2mm) and Group 2(width of
attached gingiva less than 2mm)
                                    Plague              gin.inflamation           bleeding upon probing
Group 1                     0, 45                      1, 40                                1, 56
Group2                      1, 89                      2, 46                                2, 76
t                                10,34                     6,71                                11,30
p                              <0,001                <0,001                              <0,001
Table 2. Mean values for attachment loss on different surfaces of teeth for Group 1 and Group 2
                       mezial (mm)           distal(mm)      vestibular (mm)               lingual(mm)
Group1               1,8±0,837         2,03±0,96         3,25±0,23                       2,02±0,25
Group2              3,61±1,79          4,83±0,75         5,82±1,92                       3,96±0,62
t                          5,72                    10,30              5,26                              6,71
p                          <0,001                <0,001                <0,001                     <0,001
Group 1 – (n=115) attached gingiva equal or more
than 2mm (3, 25±0,637mm)
Grup2 – (n=94) attached gingiva less than 2mm
(1, 87±0,785mm)
Results for plague and gingival index values for
both groups are shown in Tab 1. Values for plaque and
gingival indices were significantly higher in the second
group.
Measured mean values for attachment loss on
all four surfaces of teeth were also significantly higher for
the second group with attached gingival less than 2m
(Tab 2). It is worth mentioning that vestibular surfaces
showed bigger lost of attachment (5, 82±1, 92 mm) than
the other surfaces. (Tab.2)
Discussion
The general concept of our study was to identify
the influence of the width of attached gingiva on
periodontal attachment lost. This is not a new problem in
Periodontology and had been periodically discussed for
decades. For some periodontologist it is a question of
academic character and has no practical appliance, but
still the width of attached gingiva needed to maintain
periodontal health and unaltered attachment levels is a
controversial topic and no conclusive evidence have been
presented up to now. [3, 4]
It has been discussed that periodontal health
can be maintained in areas with minimal zones of attached
gingiva as long as the patient can maintain the area and
there are no restorations in the area of the gingival margin.
[7, 8, 9] Maintenance of optimal oral hygiene in areas of
narrow attached gingiva especially in the lower vestibule
is more than an impossible task. Therefore the theory of
disregarding the width of attached gingiva in assessment
of periodontal risk for the patient is sustainable only in
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ideal conditions such as regularly preformed professional
plague removal.
The problem even escalated over the past few
years when new and expensive technologies were
introduced in dentistry. Dilemmas impose in everyday
practice such as: should one apply such dentures or
implants at periodontal risk sites? If so should we demand
from patients to visit us each day for professional plague
removal for the rest of the lifetime they have this implants?
There have been suggestions of authors [10] that
when restorative procedures enter the gingival crevice, a
minimum of 5 mm keratinized tissue is required (2 mm of
free gingiva and 3 mm of attached gingiva). So some width
of attached gingiva is needed to maintain plague control.
The results from our study speak in favor of this concept.
Regions with less than 2 mm of width of attached gingiva
showed nearly two fold higher values of plague index
than the first group (1,89 for the second and 0,45 for the
first group). Results obtained for gingival inflammation
and bleeding upon probing are with accordance with
elevated plague accumulation in areas with width of
attached gingiva under 2mm.Our results are supported
by published results of other authors. [1, 2, 3]
The main aim of our study was to verify that
these areas are prone to greater attachment loss. Dorman
[11] have reported that after surgically aggravating the
width of attached gingiva there was no significant gain of
attachment therefore the width of attached gingiva will
have no influence on periodontal health or attachment
loss. Our results speak otherwise. In the first group loss
of attachment was approximately 3, 25±0,23mm and in the
second group was significantly higher 5, 82 ±1,29mm
(p>0,001) measured on the vestibular surface.
The keratinized and attached gingiva as well
provides a protective fibre barrier against inflammation
and attachment loss. The results obtained in this study
have shown that areas with narrow width of attached
gingiva seem to be prone to periodontal attachment loss,
which could result in recession of the gingival margin in
the presence of risk factors. Lang, Löe [1] have
demonstrated that such areas show clinical signs of
inflammation even in the absence of dental plaque, as
evidenced by an increase in gingival crevicular fluid (GCF)
flow rate, which suggests that tissue behavior is mainly
associated to pathological than to physiological processes
under these conditions [12].
Gingival tissue fluid transudates rather through
gingival sulcus than through alveolar mucosa in areas
presenting at least a 2mm attached gingiva width, while
areas presenting less than 2mm of attached gingiva width
shows transudation of tissue fluid by alveolar mucosa.
These findings suggest that the protective role [13] and
homeostatic response exerted by GCF is compromised in
areas with a narrow width of attached gingiva.
Furthermore, wider area of attached gingiva
favors physiological behavior of the gingival sulcus by a
better dissipation of GCF; a closer proximity of gingival
margin and alveolar mucosa influence the dissipation of
tissue fluid through alveolar mucosa, which is more
permeable and mobile, impairing primary defense of
gingival sulcus by the concentration of GCF [14, 15, 16].
Conclusion
The obtained data from our study speak in favor
of the concept that areas with width of attached gingiva
less than 2mm are periodontaly risk sites for plague
accumulation, inflammation and attachment lost. Areas
with width of attached gingiva less than 2mm are difficult
to maintain with regularly home care oral hygiene
procedure. Therefore while planning any kind of
prosestetic appliances in such regions the amount of
attached gingiva should be seriously considered.
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Abstract
During the orthodontic treatment anchorage control is the most important factor of successful treatment.
 Micro-implants are new stationary anchorage; they are osseointegrated implants, implanted in the jaw of the
patients. Skeletal anchorage system allows direct connection between screw-implant and target teeth that we need to
correct orthodontically; provides absolute anchorage and adequate tooth movement. Orthodontic treatment, using a
skeletal anchorage system, is not only effective, but it also offers a variety of treatment alternatives in challenging
cases where traditional mechanics cannot be used.
The orthodontic treatment with micro-implants is independent of patient’s cooperation; it takes shorter time;
enables harmonious occlusion and gives functional and aesthetic individual optimum.
Keywords: skeletal anchorage system, micro-implants, micro-screw, temporary anchorage device
Introduction
 Multi-bracket appliance such as edgewise
appliance has generally been used in orthodontic
treatment for alignment of maxillary and mandibular teeth.
During the orthodontic treatment anchorage control is
the most important factor of successful treatment. The
issue of anchorage has been one of the most problematic
in the field of orthodontics since all the obvious anchors,
teeth and even molars, move in a response to orthodontic
forces.The control of anchorage is one of the most critical
factors in orthodontic treatment [2].
The commonly used anchorages could be divided
into two categories, intraoral and extraoral. Intraoral
anchorage such as palatal bar, lingual arch, and the Nance
holding arch, cannot provide sufficient anchorage.
Clinicians could not expect maximum anchorage using
extraoral anchorage, such as a headgear, because, it totally
depends on the cooperation of the patient.
There have been many studies [11,12] presenting
maximum anchorage, independent of patients’
cooperation, using dental implants, surgical mini-implants,
mini-screws, and micro-screws [8]. The skeletal anchorage
system is temporarily implanted in the maxilla or the
mandible as orthodontic anchorage and it is a new
stationary anchorage implanted in the jaw -
osseointegrated implant. Miniature screw is relatively less
traumatic and frequently used in orthodontic treatment
when maximum anchorage is required, hence, they can be
used where conventional anchorage cannot be applied
[3]. Different types of head of  micro-screws had deferent
designs that are currently available on the market, and
their use depends on the particular situation [19].
Seth [35] reported that these devices have been
called by various names and some of the popular ones
are: mini implants - MI, micro implants-MI, skeletal
anchorage system-SAS, temporary anchorage device -
TAD.
Implantologists use the term mini-implant, which
is a kind of temporary implant to make temporary crown
during osseointegration of implant. The term temporary
is true for all anchorage devices. Since the primary goal of
retention of most micro-implants is a mechanical lock within
the bone, they require a tight fit to be effective. Their
stability depends almost entirely on the quality and
quantity of the available cortical and trabecular bones
[12]. Mini-implants can be fully loaded immediately after
placement, and they are removed at the end of the
treatment. They are easy to insert, safe, cause little or no
discomfort, and are simple to remove [16].The diameter of
prosthodontic implants is a little bit larger than the
orthodontic one.
This paper presents a critical review of the existing
literature referring to type of teeth movement with force.
It is usually achieved by one or two implants in the palatal
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or vestibular area or by a combination between fixed
appliances and micro-implants. The aim of this study was
to describe skeletal anchorage for single active tooth
movement, especially for correction of the upper incisors,
since it gives good result for correction of deep bite and a
gummy smile. If the patient has skeletal and dental
transversal and vertical discrepancies, unilateral or bilateral
crossbite mini-implants are used.  In case the patient has
a mandibular shift from centric to habitual occlusion,
resulting in facial asymmetry, mini-implants can be used
as the temporary anchorage device. Mini-implants can
also be used for class II correction, molar mesialization or
distalization, molar intrusion, or molar uprighting .
The advantages of micro-screws
Mini-implants can be implanted into any area of
bone in the mouth, including radicular alveolar bone
between the posterior teeth [27], usually between the roots
of the teeth (Fig.1). Micro-implants can be implanted as
well as other locations nearby the roots, it can be put in
zygomatic arch, maxillary tuberosity, palate, chin, and
retromolar area; it can provide anchorage for every kind
of tooth movement. [18].
Skeletal anchorage system has been developed
in our orthodontic treatment using a various type of
osseointegrated implant, titanium miniplate and mini-
screw. They can be used in preprosthetic treatment for
uprighting of the maxillary or mandibular molars,
particularly in the mandible, mesialization or distalization
of some irregular teeth in dental arch, space closure,
intrusion in the mandible and maxilla on groups of teeth,
and alignment of wisdom teeth.
Treatment with micro-implants offers passive
stabilization for correcting a Class II, preventing protrusion
of incisors, anchorage in lingual technique, and anchorage
of dentitions with a reduced number of teeth.
Fig. 1. Micro-implants between the roots of the teeth
The mini crew has a specific design: small size
allowing placement in any area of the alveolar bone, simple
to place and remove, low cost, inexpensive and short
interval between implantation and orthodontic force
application. Pioneers in micro-implant technology are
AbsoAnchor developers-Korean orthodontists: JH. Sung
[19], I. Kim [18], HM. Kyung [19], Bae, [2], HS. Park [30].
AbsoAnchor implants are made of high quality
titanium alloy, they feature a variety of head types, and
accept all orthodontic systems, including wires, ligatures,
elastomers, and springs. Different designs of
microimplants have appeared in the market for different
purposes. Almost all of them have a hole in the head to
attach accessories, and others have different kinds of slots
or round heads. Several types of AbsoAnchor
microimplants are available for different tasks and sites
(Fig.2). Different types of head structures can be chosen
depending on kinds of elastomers, biomechanics, sites of
placement and individual preference. In bracket head type,
two kinds of screws are designed depending on the
driving directions. Left-handed screw should turn counter
clockwise direction during driving. Depending on the
direction of moment, orthodontists can choose right- or
left-handed screws[16].
Fig. 2. AbsoAnchor types of micro-implants from Korean
orthodontists
Classification of skeletal anchorage
Skeletal anchorage devices can be classified into
two main categories. The first category is micro-implant
which is osseointegrated with the bone [34]. The second
category finds its origin in the surgical mini-implants, such
as the one used by Creekmore [11], and those described
later by Kanomi [16].
       Classification of implants used for orthodontic
anchorage suggested by Labanauskaite [21] is the
following:
• According to the shape and size: conical
(cylindrical), mini-screw implants, palatal
implants, prosthodontic implants,  mini-plate
implants, disc implants;
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• According to the implant bone contact:
osseointegrated, nonosseointegrated;
• According to the application: used only for
orthodontic purposes (orthodontic implants),
used for prosthodontic and orthodontic
purposes (prosthodontic implants).
       Selecting the proper implant site can be an important
factor in the overall success of this treatment approach.
The length of screw portion ranges from 6 mm to 12 mm.
One should always consider the depth of soft tissue when
choosing proper length of micro-implants and should have
in mind that palatal mucosa may be very thick [40]. If the
tissue is very thick, then a mini-screw of 6mm is
recommended to be inserted into the bone. Longer micro-
implants (10 mm and 12 mm) are designed to be stronger
for placement in denser bone; they lead to better
mechanical stability of dental prosthetic implants, but they
might damage anatomical structures, such as roots,
maxillary sinus and nerve [3].
        Depending on the inter-radicular distance, quality of
bone and site of placement, orthodontists can choose
different diameters of microimplants. The diameters of
screw, ranging from 1.2 mm to 2 mm and can be placed
anywhere in the mouth. The C-shaped implant is a unique
titanium device (Fig.3 a, b) that provides absolute
orthodontic anchorage, mainly from osseointegration [8].
Each implant is packed in an aseptic vial and blister pack.
The C–micro implants, with conical or cylindrical head
(Fig 3a) design, are usually placed in the interdentally
spaces between the second premolars and first molars, or
between the first and second molars [9]. This is a new
concept for temporary skeletal anchorage in orthodontic
treatment, for active tooth movement or passive
stabilization. It is of special design as are the other
products [4].
   a)                                      b)
 Fig. 3. a) Cylinder and b) Tapered C-micro implant
Common sites of placement (Fig.4a) in maxilla
are: infrazygomatic crest area, tuberoses area, between
the 1-st and 2-nd molars buccally, between the 1-st molar
and 2-nd premolar buccally, between canine and premolar
buccally, between incisors facially [27], mid-palatal area
(Fig. 4c).
Common sites of placement (Fig.4b) in mandible
are: retromolar area, between the 1-st and 2-nd molars
buccally, between the 1st molar and 2nd premolar buccally,
and between canine and premolar buccally [38]
Fig. 4. Common sites of placement in a) maxilla b) mandible
and c) mid-palatal area.
Mini-screws are modern systems that are sterile.
Each implant is packed in an aseptic vial and blister pack
[23]. Depending on the treatment goal, the different
indications can be divided into three groups: active tooth
movement, passive stabilization, or preprosthetic
treatment..
Treatment with application of a skeletal
anchorage system
One of the primary goals of orthodontic treatment
is functional stability with optimum esthetics. Therefore,
micro-implants are the best and easiest way to get absolute
anchorage for orthodontic treatment because, the problem
of anchorage has been one of the most problematic in the
field of orthodontics [21]. Skeletal anchorage was
originally developed as an adjunct to tooth-bone
anchorage for intermaxillary fixation after orthognathic
surgery [34]. Mini-screws used for active tooth movement
can correct: mandibular molar inclination (Fig.5),
uprighting of the maxillary or mandibular molars [31],
asymmetric occlusal plane, supraposition of lower anterior
teeth (Fig.6), asymmetric Class II malocclusion with “en-
masse” retraction for correction of this class malocclusion
using sliding mechanics [22], supraposition of upper
anterior teeth [28], and their uprighting (Fig.7). Micro-
implants are used for distalization and derotation of the
first maxillary molar (Fig.8), for space closure in the class
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I occlusion [20], or for correction of impaction of maxillary
canine with distalization and uprighting of these teeth
(fig.9).  All illustrations are taken  from the Dentaurum
Illustrated Atlas of Skeletal Anchorage, 2006, provided
by: OA Dr. Benedict Wilmes, Dusselforf, Germany
Fig. 5. Micro screw for mandibular molar uprighting
Fig. 6. Micro implants for  uprighting  en masse  intrusion
of lower anterior teeth
 Fig. 7. Correcting the supraposition of upper anterior
teeth and their uprighting
Fig. 8. Micro implants for distalization and derotation of
the first maxillary molar
Fig. 9.  Micro implants for distalization and uprighting
of the maxillary canine
Ohnishi [28] suggested that micro-implant can
be used for intrusion of some teeth, especially of upper
incisors, because it gives good result for correction of
deep bite and gives a gummy smile, very simply and
efficiently. If the patient has skeletal and dental transversal
and vertical discrepancies  mini-implants can be used for
correction of skeletal crossbite.  In case the patient has a
mandibular shift from centric to habitual occlusion,
temporary anchorage device can be used widely [25].
Lee [22] described this micro implants as being
anchorage in lingual technique for correcting a Class II
malocclusion, and for preventing protrusion of incisors.
Skeletal anchorage system developed in our
orthodontic treatment [12] utilizes various types of
osseointegrated implant, titanium miniplate and mini-
screw. They can be used in preprosthetic treatment of
mandible, mesialization or distalization of some irregular
teeth in dental arch, space closure, intrusion in the
mandibular or maxillar groups of teeth [6,41], and alignment
of wisdom teeth.
 Thicker micro-implant results in greater
mechanical retention, but in greater possibility for root
contact, too. Thicker micro-implants do not always
guarantee higher success rate, although there are reports
that micro-implants of smaller diameter have shown higher
success rate than thicker ones. Also, thicker micro-implants
may be hard to remove due to osseointegration. In general,
it is always more practical to choose the smallest diameter.
Some mini-screws have small heads, which can ligate and
various springs can be applied in order to move the teeth
more easily (Fig.10) [19].
Fig. 10. Mini-screw with delta coil springs
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Different designs of micro-implant
There are various applications of screw in anterior
and posterior area. We are presenting some of them and
we are going to describe how teeth can be more easily
and precisely controlled using indirect anchorage of mini-
implants.
Usually, orthodontists can use many basic types
of titanium anchor plates. These are: Dentaurum TOMAS
micro implants, T- shaped; C shaped; Y shaped, I shaped;
Quattro micro-implants, Rocky Mountain Orthodontics
RMO-Dual top anchor system, Stryker Corporation
Leibinger micro-implant universal anchorage
system,Vector TAS micro-implant.
Chung, Kim and Kook [8] have described two
components of micro-screw in the upper arch with 1.8 mm
in diameter and 8.5 mm, 9.5 mm, or 10.5 mm in length. C-
Implant has a head with measures are 2.5 mm in diameter
and 5.35mm, 6.35mm, 7.35mm in height.
 Applied forces can range from 50 to 200 grams,
depending on the quality of the bone and the orthodontic
movement desired. Kyung [18] stated that even smaller
1.2 mm and 1.3 mm micro-implants could withstand as much
as 450 g force. The surface of each plate which will be
attached to the bone is sandblasted so that it becomes
osseointegrated more readily. This force system controls
only the mode and direction of tooth movement.
Park [31] used micro-implants having dimensions
of 1.2 mm in diameter, 8 mm in length for maxillary arch, 6
mm for mandible arch, and 10 to 12 mm in length for
maxillary palate. In order to reduce possible damage of
root during implantation procedure, micro-implants are
implanted 30-40 degrees in maxillary arch and 10 – 20
degrees in mandibular arch bone.
Misch [25] explained temporary anchorage device
(TAD). It is a titanium-alloy mini-screw, ranging from 6 to
12 millimeters in length and 1.2 to 2 mm in diameter that is
fixed to bone temporarily to enhance orthodontic
anchorage. Placement is minimally invasive and often
completed using only topical anesthetic (Fig.11). They
can be inserted directly through the gingival tissue into
bone with a hand driver. In regions of thick soft tissue
and dense cortical bone, a mucosal punch and pilot hole
may be placed to help guide insertion. Stationary
anchorage is achieved by gripping mechanically to cortical
bone, rather than by osseointegration.
Fig. 11. Regions of bone density as classified in Misch
Region mark with D1 is bone with the highest
density. D4 bone has the lowest density and is not
recommended for placement. Temporary anchorage
devices (TADs) can be placed in D1 to D3 bone with a 70
to 90 percent success rate. The maxillary mid-palatal region
contains D1 and D2 bone. TADs placed in the retromolar
pad or zygomatic region may require a flap; patients
requiring such placement should be referred to a surgeon.
   Insertion technique of temporary anchorage devices
For patient’s safety and biomechanical control
Carano [4] suggests proper angle of cortical insertion
anchorage. In the posterior area in maxilla, the angle of
insertion should be 30 to 45 degrees to the occlusal plane.
In the anterior and posterior area, in the maxilla, Kravitz
[17] suggests the angle of insertion to be approximately
90 degrees to the occlusal plane parallel to the paranasal
sinus floor because such position minimizes perforation
of the sinus. In the mandible, the angle of insertion should
be 30 to 45 degrees to the occlusal plane to increase the
surface area contact between the minicrew and the thicker
cortical bone [4].
  Risks and complications of micro-implants placement
Cheng [7] described the risks of using micro-
implants in orthodontic treatment. There are potential
complications common to all implant procedures,
including: damage to anatomic structures such as nerves,
vessels, loss of a screw during placement or loading,
breakage of a screw within the bone during insertion or
removal, inflammation around implant sites. Root trauma
to the periodontal ligament or dental root may lead to loss
of tooth vitality or ankylosis. If the patient is in pain, it
usually may be derived from the contact of the implant
with the root. In such cases, micro-implant should be
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immediately removed and the condition of the teeth has
to be checked.
Another common complication is failure of the
mini-implant [7]. Miyawaki [26] described micro- implants
failure. Mini-screws become mobile, and they will not
regain stability and may need to be removed and
reinserted. Inadequate primary stability on initial
placement likely is a result of inadequate cortical bone
thickness. Soft-tissue irritation TADs placed in loose
alveolar mucosa may result in soft-tissue irritation, tissue
overgrowth and minor aphthous ulceration.
Branemark [3] described sinus complication, and
perforation of  small part of the paranasal sinus floor (<2
mm). Perforations will heal by themselves without
complications and should not affect mini-screw
stability. Larger perforations may result in sinusitis or
chronic oroantral fistula.
Another common complication is
relapse. Sugawara [37] described relapse extrusion of
intruded molars. The average relapse rate for the first and
second molar intrusion is approximately 30%.
Micro-implant has a failure rate of 5-25%
depending on the dentists’ technique, patients’ type,
insertion sites, and usually failure occurs more often on
mandible rather than maxilla [7,36]. However, many
orthodontists are still hesitating to use orthodontic micro-
implants, because they are afraid of surgical intervention
and post-surgical complications.
Conclusion
Micro-implants have become very popular in the
orthodontic community in recent years for providing
anchorage. Micro-implants are especially useful in adult
patients.Orthodontic treatment has become an important
aspect of dental practice because the number of adult
patient who receive treatment has increased. Other
advantages include their relatively small size which results
in minimal anatomical limitations; they are user-friendly;
have immediate loading potential, adaptability to
biomechanics in effecting orthodontic and orthopedic
forces; high success rate, low cost and most importantly
patient acceptability.
Small-sized orthodontic micro-implants allow
easy placement with minimal anatomic limitations. The
criteria of micro-implant success are: no inflammation of
the soft tissues surrounding the micro- implant, no
clinically detectable mobility, and anchorage function
sustained until the end of the purpose for which the
implant was used.
Advantages of mini-screws are: applicability at
any stage of development, interceptive therapy, shorter
treatment time, since there is no need to prepare dental
anchorage; independence of patients’ cooperation,
patients’ comfort and low cost.
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OCCULT   BREAST   LESIONS - PERCUTANEOUS   PREOPERATIVE   NEEDLE   LOCALIZATION
Abstract
Mammographic examination of the clinically normal breast can identify some breast masses before they
become palpable. In order to remove them successfully a surgeon requires the help of some localization procedure. The
only method recommended is preoperative needle localization under control of mammography or ultrasound.
The aim of this study was to show our experience in percutaneous preoperative needle localization.
Our experience with 69 clinically occult breast lesions is presented. The localization of most clinically occult,
mammographically detected lesions was done by using mammographic guidance. We used perforated compression
plate, local anesthesia and Bard hook wire.
The mean age of patients was 52.33 years. The major indications for localization were microcalcifications
(37.68%).
The overall incidence of malignancy observed was 47.83% and of benign lesions 50.72%. We used single wire
in 62 patients and two wires in 7 patients. Mammography guided localization was done in 81.16% of patients and
ultrasound was used in 18.84%.
Percutaneous needle placement is a simple method of localizing occult lesions found by mammography.
Key words: occult lesion, hook wire, localization, breast cancer
Introduction
Breast cancer is the most common cause of
women death in Macedonia. The war against breast cancer
is being won by detecting small cancers. Our imaging tools
are mammography and ultrasound. Mammography can
detect clinically occult breast cancer. However, minimal or
no physical findings of the lesion can be quite difficult to
be detected by a surgeon. Microcalcifications can be
detected only by mammography. When there is a
nonpalpable cancer in a dense breast, clustered
microcalcifications are on the primary x-ray mammographic
findings and sometimes they are the only findings (1).
Localization of nonpalpable, mammographically
and ultrasound detected breast lesions is a well
established technique which we believe to be safe, rapid
and accurate method for small and highly curable breast
cancers.
The methods developed for preoperative
localization of breast lesions may be grouped into those
using external and internal markers. External markers are
located on the skin based on coordinates determined at
mammography. It might be difficult to apply this method
for deep lesions since the lesions seen during surgery
might be different from what was seen on mammography.
Using internal markers involve the insertion of a needle
into or near the nonpalpable lesion (2). This lesion is
marked by inserting  a hooked wire with a needle so that
the surgeon can localize it more easily.
Material and Methods
This retrospective study reports the results of
69 outpatient procedures using needle localization during
the period of 2009-2011 at the University Clinic of
Radiology in Skopje.
We make use of the mammomat Hologic
Inspiration and ultrasound Aloka with linear array 7.5MHz
- 10MHz. Mammography was the initial procedure applied
in all asymptomatic and symptomatic women over the age
of 40. It was followed by sonography. The selection of
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which modality to be used for guidance depends on: (1)
the adequacy of visualization of the lesion by the modality
used, (2) the position of the lesion, (3) the ease of
positioning the patient, (4) the need to reduce the radiation
exposure, (5) the skill of operator, (6) the overall patient
condition, (7) size of the lesion. All lesions were localized
using a Bard-hook wire technique. We approached all
lesions with the needle parallel to the chest wall, using a
superior approach for lesions in the upper two thirds of
the breast and inferior approach for lesions in the inferior
one third of the breast. Dedicated mammographic
equipment should be used to obtain high quality images.
Mammograms should always be interpreted on dedicated
high - luminance mammographic view boxes and
magnifying glass should be used routinely. We always
compare current mammograms with prior mammograms to
determine the stability of any calcifications detected. Local
anesthesia (lidocain 1%) is administered in the skin and
subcutaneous tissue. The specimen is radiographed in all
cases.
Results
Table 1 presents the mean age of the patients
and Table 2 presents the age distribution of the patients
with benign and malignant lesions.
Of the 69 cases, 34 were positive for cancer and
35 were benign breast lesions (Figure 1).
Table 1.  Age of the patients
Descriptive Statistics
Age      Valid N     Mean     Confidence-95%     Confidence+95%     Min.    Max.    Std.Dev.    Stand.Error
years    69            52.33     49.98                     54.68                      30.00   74.00   9.77         1.17
Average age for patients is 52.33±9.8 years
Table 2.  Age distribution of benign and malignant lesions
t-test for independent samples
Age     Meanbenign     Meanmalignant     t-value     df     p     Valid N   Valid N    Std.Dev.    Std.Dev.
years   51.17           53.52                 -1.0          67     0.32   35           34           10.8          8.5
Average age for patients with benign lesion is 51.17±10.8 years;Average age for patients with malignant lesion is 53.5±8.5
years;There is no significant statistical difference between two groups of patients.
Fig. 1.  Distribution of malignant and benign lesions
The major indications for localization were
microcalcifications in 26/69 (37.68%) patients and a mass
without calcifications in 22/69 (31.88%) patients.
Forty-seven of the patients had nonpalpable, but
mammographically suspicious lesion and twenty- two
were clinically indeterminate.
In 56 cases (81.16%) localization was done by
mammography and in 13 (18.84%) by ultrasound . We used
a single wire in 62 patients and two wires in 7 patients.
The spectrum of dominant morphologic
characteristics of the benign masses is outlined in Table
3.
The distribution of malignant histopathologic
findings is shown in Table 4.
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Table 3.  Distribution of benign histopathological findings
Benign Histopathological Findings N %
Mastopathia 14 40
Fibroadenoma 6 17,14
Mastopathia fibrocistica 3 8,57
Blunt duct adenosis 1 2,86
Fat necrosis 1 2,86
Sclerosing adenosis 7 20,0
Papilloma intraductale 3 8,57
Total: 35 100
Table 4.  Distribution of malignant histopathological findings
Malignant Histopathological Findings N %
Carcinoma ductale invasivum 21 61,77
Multicentric carcinoma 1 2.94
Carcinoma ductale in situ 4 11.76
Carcinoma tubulare 4 11,76
Carcinoma lobulare invasivum 3 8.82
Carcinoma papiilare invasivum 1 2.94
Total: 34 100
There were no complications that resulted from
preoperative hook localization in our study.
We present some interesting cases in Figure 2, 3
and 4.
Fig 2.  Mammografic presentation of ductal carcinoma in situ.
     Fig. 3. Mammografic presentation of small carcinoma
Discussion
Widespread use of mammography has resulted
in detection of an increasing number of suspicious, but
nonpalpable lesions. The tumors that are not palpable in
the breast because of their location carry the same risk as
palpable cancers of the same size and histological type.
Screening programs employing mammography, designed
to detect breast cancer in this pre-palpable stage are
encountered as a means of uncovering a higher proportion
of such cancers at an earlier stage in their natural histories
(3).
Percutaneous needle placement is a simple
method of localizing occult breast lesions found by
mammography (4).
The mean age of our patients with malignant
disease was 53.5 years. In Marrujo’s study, cancers
tended to occur in younger women, average age of 52
years (5).
The most frequent benign histopathological
finding was mastopathy (fibrocystic and displasia) and
malignant finding was ductal carcinoma. The incidence of
malignancy in our study was 47.83%, which was in
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Fig. 4.  Magnification of hook-wire localization of small
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agreement with literature. Schwartz et al. reviewed 469
cases with malignancy rate of 32.2% (6).
Rosenberg reported 27% of malignant lesions
and Leis 38.2% (7, 8). Higher percent of malignancy
detected in our patients can be described with the fact
that the University Clinic of Radiology is the unique public
center for needle localization in our country.
In the reported literature series involving needle
localization technique, the predominant pathological
cancer type was the ductal one (9, 10). We identified only
one case of multicentric disease.
In our study 81.16% of the lesions were localized
under mammography control because we consider it to be
more precise when the lesion is smaller and the breast is
bigger.
We reported 50.72% of lesions located in upper
and lateral quadrant, which can be compared with those
in literature (11, 12).
There were no complications during performing
the procedure, while literature consulted had reported 0-
0.2% complications (13).
Surgeons are urged to resect nonpalpable breast
lesions only detected by mammography and ultrasound.
The precision and success are related to the radiologists’
experience in marker placement.
We found the verbal communication between
radiologists and surgeons to be particularly helpful with
reference to the position of hook wire and target lesion.
Relevant mammograms should also be available in
operating rooms.
Conclusion
In order to remove occult lesion successfully, a
surgeon requires the help of a localization procedure.
Preoperative wire localization is an integral component in
the early detection of breast carcinoma.
The technique is easy and painless. Its precision
and success relate to close cooperation between the
radiologist, surgeon and pathologist.
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EVALUATION   OF   MANNHEIM   PERITONITIS   INDEX   IN   PATIENTS   WITH   SECONDARY   AND
TERTIARY   PERITONITIS
Prognostic evaluation of patients with peritonitis is needed in order to program correct medical treatment, to
plan more aggressive therapeutic procedures and to predict the outcome.
This study was performed to evaluate the value of MPI in patients with secondary and tertiary peritonitis for
the prediction of surgical outcome.
Clinical, imaging and laboratory data of 36 patients with secondary and tertiary peritonitis were analyzed.
MPI was calculated and outcome was predicted in two categories: < 26 and  > 26 points.
Indicators of severity of the disease were correlated to outcome and MPI.
Inflammatory palpable mass, constipation and stop of flatus, arterial blood preasure, oliguria <20 mL/h,
urea>167 µmol, creatinine >177 µmol, pO2  < 50 mmHg, pCO2 > 50 mmHg and radiographically hydroaeric levels were
in correlation with the fatal outcome of the patients. There was a strong correlation between MPI and death and among
MPI and above mentioned parameters.
We conclude that MPI is a useful tool to determine the outcome in patients with peritonitis which is easily to
calculate and has good accuracy.
Key words: Peritonitis, Mannheim index, Mortality predictor
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Abstract
Peritonitis is one of most urgent and important
infectious problem in every day surgeon’s practice.
Despite the progress in treatment of the patients with
peritonitis, the mortality rate is still high, ranging from 5%
to 50%, depending to the severity of the disease (1-5).
The prognosis in these patients is strongly
influenced by the previous health status, many risk factors
and the appropriate management of the disease, including:
controlling the infective source, elimination of
microorganisms and toxins, maintaining of systemic organ
function and controlling the inflammatory process (6-10).
The management of peritonitis requires a
competent care, minimizing of risks, urgent decision
making and aggressive surgical intervention. The
reoperation if needed, have to be made immediately to
achieve benefit for patients (8-12).
Introduction Prognostic evaluation of patients with peritonitis
is needed in order to program correct medical treatment,
to plan more aggressive therapeutic procedures and to
predict the outcome (13,14).
There are many scoring systems for the
prediction of outcome in patients with peritonitis.
More of the scoring systems are based on
elements provided by patient’s clinical signs, systemic
signs of sepsis and complications that influence organs
function. These systems are useful in predicting the
outcome of patients with severe illness admitted in
Intensive Care Units, and in patients with peritonitis
especially because their outcome becomes poor in a phase
when a multiple organ dysfunction develops, despite the
evident achievements in medical and surgical treatment
(15,16).
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Mannheim Peritonitis Index (MPI) was
developed by Wacha and Linder in 1983, based on
analysis of 1253 patients with peritonitis, in which 20
elements were analyzed. Eight of them proved to be
relevant and were incorporated in MPI, classified
according to their predictive value (15-17).
The effectiveness of MPI was confirmed by
investigations made in several European surgical  units
and some authors consider MPI as  more practical than
the other scoring systems. It has an acceptable specificity
and sensitivity (13, 18,19).
This study was performed to evaluate the value
of MPI in patients with secondary and tertiary peritonitis
for the prediction of surgical outcome.
This clinical study was done during a period of 3
years, from January 2008 to January 2011 and 36 patients
(20 female and 16 male) with secondary (SP) and tertiary
peritonitis (TP) were included. Patients younger than 18
years and older than 80 years were excluded. The younger
patients than 18 years were excluded because of their
treatment in another surgical department and the older of
80 years were excluded because of their severe comorbidity
due to the age. The youngest patient had 26 and the oldest
79 years and overage age was 54,2 year.
Every patient was worked-up as follows: Clinical
history, physical examination, blood, serum and urine
investigation, abdominal X-ray and abdominal ultrasound.
A CT scan was performed for some of the patient, if the
clinical doctor asked for it. Operation was performed
trough a midline laparotomy incision, when diagnose of
acute abdomen was made. All 36 patients underwent
laparotomy, elimination of the sources of infection,
aspiration of intra-abdominal exudates, debridement, a
lavage with 4-5 liters normal saline and insertion of
abdominal drains. A nasogastric tube was placed to all
patients. They all received intravenous fluid and
antibiotics. Ceftriaxone (Na) 2gr/day was infused in two
separate doses 5-7 days. The patients with genitourinary
source of infection and those who underwent
anastomosis, got an additional therapy of metronidazole
3x500 mg/day IV, 7days. If needed, antibiotics were
changed, according to the microbiological findings.
Analgesics were administered as required.
The following data were examined: pain,
vomiting, distension, constipation, stop of flatus,
inflammatory palpable mass, tenderness, muscle rigidity,
blood pressure, pulls, fever, oliguria <20mL/h, ileus >24h,
Risk factor          Points
Age>50 y                 5
Female gender 5
Organ failure 7
Malignancy 4
Preoperative duration of peritonitis >24h 4
Non colonic origin of sepsis 4
Diffuse generalized peritonitis 6
Exudates
Clear 0
Purulent 6
Fecal 12
Patients and Methods
coma, neurtophils, urea>167 µmol, creatinine >177 µmol,
pO2  < 50 mmHg, pCO2 > 50 mmHg (oliguria, urea,
creatinine, pO2 and pCO2 according to MODS - Multiple
Organ Dysfunction Syndrome). Radiographs were
analyzed for hydroaeric levels and free liquid or gas, and
ultrasound findings were analyzed for free liquid, peristalsis
and collection of pus. Complications were considered as
leakage, dehiscence, wound infection, abdominal
compartment syndrome and sepsis.
MPI was calculated and outcome was predicted
in two categories: < 26 and  > 26 poens.
Data were analyzed using SPSS software and
normality distribution test (Kolmogorov-Smirnov), mean
value, frequencies and Spaerman’s coefficient of
correlation r, were done.
Table 1.  Mannheim peritonitis index
Of 36 patients with secondary peritonitis 6
patients (16,6%) developed tertiary peritonitis. Six patients
(21,4%) died in hospital after medical treatment, 3 of them
with secondary peritonitis and 3 with tertiary peritonitis.
Three of them developed multiple organ failure, 2 died
due to sepsis and 1 of the patients died due to respiratory
failure. Eight patients (22,2%) developed local
Results
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complications including wound infection (5), abscess (1),
suture dehiscence (3). One of the patients developed
MRSA infection.
Intra-hospital treatment last from 3 to 37 days, a
mean of 11,19 days; 2 patients spent more of 30 days in
hospital.
All of them had variable feeling of pain,
distension, tenderness and objectively some level of
muscle rigidity.
The statistical analysis showed that all of the
parameters shown in table 2 were in correlation with the
fatal outcome of the patients. There was a strong
correlation between MPI and death and among MPI and
above mentioned parameters.
Source of peritonitis, its type and outcome of
patients are shown in table 3.
Relation of patients MPI to fatal otcome is shown
in table 4. The non-survivor patients MPI range was 30-
40 points, a mean of 34, and the survivors MPI range was
15 - 26 points, a mean of 23.
Peritoneal infections may be primary, secondary
(SP) and tertiary (TP).
Primary peritonitis or spontaneous bacterial
peritonitis (SBP) occurs without evident intra-abdominal
source of infection. It is an uncommon disease often
associated with urinary or hepatic pathology and almost
exclusively observed in patients with ascites due to
chronic liver disease. Primary peritoneal infections were
not an object of this analysis (21).
Secondary peritonitis most often is a result of
bacterial contamination of sterile peritoneal cavity due to
a perforation of a hollow organ, transmural infection or
external source. Sterile chemical irritants as bile, blood,
gastric juice in the first several hours, ischemic injuries or
latrogenic trauma (endoscopy procedure) may also be a
cause of SP. The incidence of SP varies from less than 2%
in patients with elective abdominal operations (leakage,
anastomosis dehiscence, intestinal injury) to 10% in
patients with inflammatory disease and 50% in patients
with hollow organ perforation and gangrenous bowel
disease (21).
Discussion
There were 6 (16,6%) postoperative peritonitis
in our study due to local complications and 16 (44,4%)
cases of peritonitis due to hallow organ perforation.
Tertiary peritonitis occurs as a persistent or
recurrent peritoneal infection following adequate therapy
of SBP or SP, most often without the original visceral organ
pathology. It is often seen in patients with significant
preexisting comorbidity or in immunocompromised
patients and is usually presented as an abscess or
phlegmon inflammation. Mortality rate in patients with
TP ranges from 50% to 70% (21).
In our study TP developed in 5 cases (13,8%)
after proper treatment of SP due to hollow organ
perforation and in 1 case (2,7%) of postoperative
peritonitis.
Clinical manifestations of peritonitis are
abdominal pain (first dull, than severe), anorexia, nausea,
vomiting, abdominal tenderness, rebound tenderness,
increased abdominal wall rigidity, fever with temperatures,
paralytic ileus. With time tachycardia, hypotension,
decreased urine output and septic schok occur (15,21).
Despite the progress in antimicrobial agents and
the advances in intensive care procedures and surgical
techniques intra-hospital mortality rate of peritonitis
continuously remains high. Therefore the peritonitis
remains one of the most serious problems for surgical
treatment (9,13,14,16,22).
Many different factors as age, duration and extent
of peritonitis, site of perforation and delayed surgical
intervention influence the prognosis and outcome of
peritonitis (9,16).
Parameters like pulse, oliguria, level of creatinine
and urea, pCO2, pO2 are considered to be indicators of
severity of peritonitis (23).
We found out inflammatory palpable mass,
constipation and stop of flatus, arterial blood preassure,
oliguria <20 mL/h, urea>167 µmol, creatinine >177 µmol,
pO2  < 50 mmHg, pCO2 > 50 mmHg and radiographically
hydroaeric levels to be indicators of severity of the disease,
also.
The outcome therefore is difficult to predict and
depends upon early surgical intervention, source control,
adequate intaoperative peritoneal lavage and complete
intensive care (9,16).
Early objective grading system of severity of
peritonitis is needed for appropriate medical and surgical
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Table 2. Statistically significant correlation to fatal outcome
Parameter No of cases % p r
Inflammatory palpable mass 10 27,7 p<0,05 0,331
Constipation and stop of flatus 26 72,2 p<0,05 0,331
Arterial blood pressure  8 22,2 p<0,05 -0,678
Oliguria <20 mL/h 4 11,1 p<0,01 0.661
Urea>167 µmol 6 16,6 p<0,01 0,837
Creatinine >177 µmol 8 22,2 p<0,01 0,679
pO2  < 50 mmHg 9 25 p<0,01 0,617
pCO2 > 50 mmHg 8 22,2 p<0,01 0,679
Hydroaeric levels (Rtg) 12 33,3 p<0,05 0,378
MPI 36 100 p<0,01 0,836
Table 3. Cause of peritonitis, outcome and type of peritonitis
Cause of peritonitis No cases Outcome Type of peritonitis
Duodenal perforation 1 ex SP
Gastric perforation 1 - SP + TP
Gastric perforation 2 - SP
Small intestine perforation 4 - SP
Small intestine perforation 2 - SP+TP
Small intestine gangrene 4 - SP
Morbus Chron 3 - SP
Colonic perforation 5 - SP
Colonic perforation 2 ex SP+TP
Genitourinary tract perforation 1 ex SP
Tubo-ovarian abscess 3 - SP
Postoperative peritonitis 1 ex SP + TP
Postoperative peritonitis 1 ex SP
Postoperative 4 - SP
Carcinomatosis 2 - SP
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Table 4. MPIcalculation and relation to death
MPIcalculation No cases % ex %
< 26 points 28 77,7 0 0
> 26 points  8 22,3 6 75
The non-survivor patients MPI range was 30- 40 points, a mean of 34, and the survivors MPI range was 15 - 26 points,
a mean of 23.
treatment, planning aggressive surgical procedures and
predicting the outcome. It is needed for programming the
most adequate therapeutic plan and selecting the high-
risk patients for reoperation. The scoring systems also
help in evaluating the risks, comparing the effectiveness
of different treatment procedures and assuring quality of
care (6,9,16,)
Many prognostic scoring systems are used for
appropriate prediction of outcome of the disease: score
of Elebute and Stoner, SSS (Sepsis Severity score) , PIA
(Peritonitis Index Altona), MOF (Multiple Organ Failure),
APACHE II (Acute Physiology and Chronic Health
Evaluation), SAPS (Simplified Acute Physiology Score),
MPI (Mannheim Peritonitis index) (13,15-19,23,24).
The score of Elebute and Stoner and SSS
developed as the earliest scoring systems and are
considered as scores with limitations (24).
PIA is based upon history, physiological data,
clinical examination and intraoperative findings. MOF
score is based upon dysfunction of pulmonary,
cardiovascular, hepatic, renal, gastrointestinal, nervous
and hematological system.  APACHE II system is based
upon physiological findings and has a large range of
scores that enable risk calculation and correlate to the
mortality. MPI is based upon preoperative and operative
data and is designed specifically for peritonitis (13,15,24).
We evaluate the value of MPI in patients with
secondary and tertiary peritonitis for the prediction of
surgical outcome as a scoring system designed
specifically for peritonitis.
Many authors reported MPI as a qualitative
predicting score for patients with peritonitis (13-19,21,22).
Pacelli et al (1996) calculate prognostic
significance of several variables including APACHE score
II and MPI in patients with intra-abdominal infections (IAI)
and found out that both score systems correctly graded
IAI severity and were strongly and independently
associated with the outcome. The MPI was easier to apply
(10).
Notash at al (2005) compared efficiency of MPI
and MOF in patient with peritonitis and concluded that
MPI has been shown to be an appropriate objective
prognostic factor in patients with peritonitis to predict
their outcome. The author commented that accuracy of
MPI was comparable or slightly superior to that of other
sepsis classification systems, including APACHE II (13)
Our results correspond to the findings of other
authors who considered MPI as a specific score with good
accuracy that in easy way provides prediction of
individual prognosis of patients with peritonitis (13-
19,21,22).
We conclude that MPI is a useful tool to
determine the outcome in patients with peritonitis which
is easily to calculate and has good accuracy.
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SURGICAL    TREATMENT   OF   PRESSURE   ULCERS
Tudzarova Gjorgova Smilja, Peev I, Naceska A
University Clinic for Plastic and Reconstructive Surgery, Medical Faculty, Skopje, Macedonia
Abstract
Pressure sores or bedsores are injuries to the skin and underlying tissues that result from prolonged pressure
on the skin. Bedsores most often develop on areas of skin that cover bony parts of the body, such as the heel, ankles,
hips or buttocks. These wounds most often present themselves in immobilized or bedridden patients on parts of the
body that are compressed between the skeleton and underlying surface. The treatment is often long lasting, time
consuming and management is difficult process that demands enormous financial and human resources.
The aim of this paper is to present our experience with the surgical treatment of the deep pressure sores. Our
study presents a cohort of 30 patients that were surgically treated at the University Clinic for Plastic and Reconstructive
Surgery, in Skopje, Republic of Macedonia, during a fifteen year period from 1996 to 2010. Emphasis of the surgical
treatment was placed on harvesting and transplanting  cutaneous and myofasciocutaneous flaps in order to cover the
deep soft tissue defects. Results include statistical analyses of the group, systematization of the pressure ulcers
according to the regions affected, utilized operative techniques as well as the average hospitalization stay. The
youngest patient is a 10 years old child with a scalp pressure ulcer following a neurosurgery operation. The oldest
patient is 83 years old male with a decubitus in the sacral region. Mean hospitalization stay is 26 days. Surgical
treatment of the decubital ulcers, adequate and on time applied, in combination with appropriate pre- and post-
operative care, gains satisfying functional and aesthetic results. That applies especially in selected patients where
primary illness as reason for pressure ulcer is prone to successful rehabilitation.
Key words: decubitus, reconstruction, flap
Introduction
Decubital ulcer, pressure sore, pressure ulcer, bed
sore or simply  decubitus are all synonyms that refer to
wound occurring due to long-lasting excessive pressure
over the tissues which are compressed between the bone
prominences   and  external objects. These objects could
be anything that creates  compression over the soft tissue
like beds, mattresses, wheelchairs etc. On the other hand,
the bone prominences usually are sacral, ischial,
trochanteric, calcanear, spine processi, calvaria and other
parts of the skeleton comprising the most affected regions.
(1,2)
The term decubitus originates from the Latin
word “decumbere”, which means “to lay”, “to lie on”
inducing the fact that these wounds have been seen
initially in patients  lying immobile for longer time. As a
medical problem, pressure ulcers seem to be as present as
the civilization, as  J. Thompson Rowing in 1961 has
described a decubital ulcer in Egyptian mummy. Sir James
Paget in 1873 was first to explain the pathophisiology of
these ulcers. Namely, the main reason for decubital ulcers
is the pressure exerted over the tissues which can
withstand a short termed   high pressure, but not
prolonged. When this compression rises to level higher
than the capillary filling pressure, which is approximately
32mm Hg, a process of hypoxia and ischemia occurs
leading to cell death and tissue necrosis. Furthermore,
uninterrupted and prolonged pressure causes thrombosis
of the small arteries and veins, additionally contributing
to tissue necrosis and subsequent inflammation. This
common pathway initiates the magic circle towards
pressure ulcer and can occur after as little as 2 hours of
unrelieved overpressure. Tissue resistance to pressure
and hypoxia differs among distinct cell types regarding
their dissimilar oxygen needs, as muscle cells are more
amenable to ischemia than the overlying skin which can
bear as long as 12 hours over-pressed without appearing
any signs of ischemia. This is the reason for wider and
deeper necrotic areas than expected when seen on initial
patient inspection. Time needed for pressure ulcer to
develop also depends on patient weight, blood supply of
the tissue, concomitant local infection, maceration and
other contributing factors (1-3).
Any patient with impaired mobility is prone to
pressure ulcer occurrence such are comatose or sedated
patient, patient with quadriplegia/ paraplegia, heavily or
terminally ill patient, burned or polytraumatised patient.
While immobile, they can’t assist when needed in order
to inhibit long-lasting over pressure thus being susceptible
to pressure sores unless medical stuff prevent it. Muscle
Acta morphol. 2011; Vol.8(2): 65-71
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atrophy seen in prolonged immobilizations or neurological
impairments, is the reason for de-bulking the bone
prominences. The lack of sensibility in spinal cord injuries
makes skin thinner and more vulnerable to friction and
traction forces, which break down skin barrier, resulting
in macerations that adhere to clothes and injure the skin
additionally. Also, insensibility means painless, thus
annulling the main symptom of injury, the pain. On the
other hand, wound presence postpones the rehabilitation
program which is of great importance for these patients.
Furthermore, other local factors and
comorbidities do contribute. Local factors comprise bad
hygiene, urinary or fecal incontinence, moist and wet
environment, lack of effective dressings, infections.
Comorbidities like anemia and malnutrition are of great
importance, due to the fact that both decelerate wound
healing and aggravate catabolism. Vascular abnormalities
as seen in diabetics stress out the probability for sore
appearance (3, 4, 5).
Out of many staging classifications, the one of
Shea modificated by National Pressure Ulcer Advisory
Panel is widely used. Comprising 4 stages of ulceration,
this system describes the depth of the sore. First stage is
presented as non-bleachable erythema, induration, pale
color, but still an intact skin. Second stage presents a
partial thickness skin loss that involves epidermis and
possibly dermis, usually seen as blister or superficial ulcer.
Stage III refers to a full thickness skin loss and sub dermal
tissue necrosis with an unaffected fascia. Stage IV
represents the deepest ulcer involving fascia, muscle,
tendons, joint capsule and probably bone. At this stage,
osteomyelitis is often seen as well as deep undermining
sinus tracts that destroys the tissue in the vicinity. A
practical staging system divides pressure ulcers in shallow
ulcers (stage I and II), deep ulcers (stage III and IV) and
ulcers where the depth cannot be evaluate at the moment
of inspection due to present necrosis that need to be
debrided (6).
The complex treatment of pressure ulcers is time
consuming, demanding and slow going process that
employs lot of resources and efforts. Modern approach
of the treatment comprises adequate handling of the
primary illness, prevention with all means especially usage
of anti-decubital beds and mattresses that eliminates
overpressure, correction of comorbidities like anemia and
hypoproteinemia, employing optimal wound healing
environment and finally, surgical treatment. Shallow ulcers
are treated conservatively whereas deep ulcers
conservatively or/and surgically.
Interest of this paper is the surgical treatment of
deep pressure ulcers i.e. pressure ulcers of stage III and
IV. Surgical treatment is applied when the general condition
of the patients allows operation. By using various
reconstruction methods the intention is to close the ulcer
as soon as possible, but as well to shorten the hospital
stay and accelerate the rehabilitation process. Pressure
ulcer surgery includes following basic principles when
utilized: ulcer and surrounding scar excision, removing of
the underlying pressure point bone (ostectomy) which is
seldom infected and lastly, reconstruction of the defect,
covering dead space, restoring contour with similar  and
stable  tissue by using various flap transfers. Prior
reconstruction, radical necrectomy is a must and includes
removing not only of the dead tissue, but also the
surrounding scar and even the granulations out from the
wound bed. The resulting defect is thus far larger and
primary closure is practically impossible to conduct.
Sutures have to be placed without any tension, on contrary
the wound will dehiscence and the reconstruction is
doomed to fail. Inclusively, usage of flaps, local or distant,
is obligatory concerning the fact that primary closure is
infeasible, expect maybe in few cases with smaller and
narrow sores (2, 7).
Patients where good result with minor recurrence
risk is expected are enrolled for surgery. This means
patients with good general condition preoperatively
assessed, patients with complimentary social resources
(social support, anti-decubital beds, adequate home
medical care, wheelchair mattresses etc.), compliant
attitude and knowledge to prevent recurrence. To minimize
operative risk, as well as to enhance the success rate, all
comorbidities should be corrected, especially anemia,
hypoproteinemia (obtaining serum albumin level > 35g/l),
glycemic level in diabetics. Good overall health and mental
states, younger age, sufficient nutritional status, negative
smoking history and absence of urinary or/and fecal
incontinence indicate satisfying outcome.    Postoperative
infection is minimized if bacterial load is less than 106 /g
tissue from decubital site. To accelerate wound cleansing
and to promote healing after necrectomy, modern dressing
technologies (impregnated alginates, hydrocolloids,
autolytic gels, adhesive barriers etc.) are used more
frequently as they absorb much discharge, provide
adequate moisture environment, stimulate necrolysis but
also decrease odor often present in combination of daily
whirlpool and high pressure saline irrigation as well as
vacuum assisted closure. Yet another modus in treatment
is hyperbaric oxygen therapy which stimulates granulation
tissue growth by obtaining optimal local oxygen level   (3,
7, 8).
Material and Methods
The study comprises all operatively treated
patients on the University Clinic for Plastic and
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Reconstructive surgery, Medical faculty in Skopje,
Macedonia, in the period of last fifteen years, from 1996
to 2010. Out from 30 patients, 21 were males (70%). The
average age is 58.6 years     (range 10 – 83). The youngest
patient is a 10 years old boy presented with an occipital
pressure sore, due to previous brain surgery and
prolonged comatose state. The oldest patient is an 83
years old male with a decubital ulcer on sacral region due
to a lasting immobility. Inclusion criteria are pressure ulcer
stage III and IV, conscious patients, good general health
status, adequate social support with expected sufficient
rehabilitation and postoperative prevention of decubital
recurrence, serum albumin level > 35g/l, wound bacterial
contamination less than 106 CFU/gr. wound tissue,
absence of anemia. Exclusion criteria are pressure ulcer
stage I and II (where conservative treatment is treatment
of choice), infections, hyperpyrexia, sepsis, concomitant
injuries and severe diseases of other nature, quadriplegia
as well as patient without social support and affected
mental status wherein no postoperative rehabilitation
process could be followed  and recurrence is expected.
Age is not criteria, but younger patients are advanced.
Etiologically, most of the patients were spinal
cord injured with paraplegia, comprising 24 patients (80%).
Three patients (10%) had the ulcer as a result of prolonged
unconsciousness after neurosurgery. Two (6.66%) had
the ulcer due to hospitalization in the intensive care unit
for longer time. One patient (3.34%) was immobile for few
months at home after hip replacement surgery and that’s
our oldest patient.
According to pressure ulcer localization, patients
are classified  into regions as following: sacral region
pressure ulcer in 15 patients (50%), trochanteric region in
7 patients (23%), occipital region in 4 patients (13%) and
other regions affected in 4 patients (13%). On inspection,
prior operation, sores are measured and  staged, using
the Shea decubitus staging system (modification by
National Pressure Ulcer Advisory Panel). Stage III is
present in 19 patients (63%), whereas stage IV in 11
patients (37%). Majority of the cases emphases decubital
ulcer with dimension ranged from 5cm2 to 10 cm2. Data
relating decubitus distribution in the group according to
etiology, localization, stage and dimension is summarized
in Table 1.
Good nutritional status is obtained by
hypercaloric, rich in protein diet, for optimizing albumin
blood level more than 35g/l. Occasionally,  parenteral or
enteral nutritional solutions are administrated prior
surgery. Preoperative blood samples are taken in order to
reveal any abnormalities.  Correction of anemia is also
imperative. Additional supplements, vitamins and minerals
are used as well. While preparing for surgery, it is
necessary  to clean and dress the wound bed in order to
reduce bacterial load which is measured by frequent tissue
biopsy or/and microbiology swabs. Necrectomies,
dressings and saline irrigations are done ambulatory, thus
preparing the wound bed as soon as possible. By using
hydro gels that speed up local autolytic processes and
high-absorbent pads, like alginates, silver alginates and
hydrocolloid barrier dressings, we enhance cleaning faster
than by using the traditional gauze dressings.
Operation in general anesthesia is planned at the
most appropriate time for the patient, when  general health
parameters and local wound characteristic allow
aggressive treatment. Operative technique includes radical
excision of whole necrotic tissue with the surrounding
scar and granulations, thus reaching the bone prominence.
When necessary, bone prominence is ablated after which
Table 1. Distribution of pressure ulcers in the group according to etiology, localization, stage and dimension
Localization Etiology Stage Dimension
Sacral region            15 Spinal cord injury       24                      III stage –
                               50% with paraplegia           80% 19 >10 cm²        7
Trochanteric            7      Brain injury and           3                        63%                       33%
region                     23%      comatose patients       10%
Occipital                   4                   Prolonged intensive    2                      IV stage –
region                      13%               care unit  admittance    6.66% < 10 cm²       23
Others         4                 Immobilization          1 11                     77%
(ischiadic, heels)      13%          3.34% 37%
This table shows that sacral region is most affected, whereas patients with spinal cord injury are most frequent.
Decubitus with III stage is in predominance as well as pressure ulcer smaller than 10cm2 in surface area.
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designing and rising the flap for covering the defect
follows. Local flapping is the most appropriate type for
reconstruction dealing with the depth and location of these
defects.  Concerning the different region and magnitude
of the defect to be reconstructed as well as  the quality of
the nearby skin, which is often damaged, it is impossible
to use one uniform flap pattern in each defect. Thus,
designing the flap is of great importance for successful
operation whereto we pay great attention. Whether
adjacent muscle is to be included in flap design or not,
depends mostly on wound depth and necessity for
optimal bone padding. If bone is ablated and  wound is
not that deep, cutaneous flap is rather used. Vice versa, if
bone is not affected, (ulcer stage III), not ablated, in thin
patients  with deep wounds, than musculocutaneuos flap
is rather utilized. That is why we apply variety of flap
patterns. Cutaneous flaps are used in 22 patients (73%),
whereas myocutaneous in 8 (27%). In one trochanteric
decubitus, m.tensor fasciae lata myofasciocutaneous  flap
is designed whereas  in 1 trochanteric,1 ischiadic and 5
sacral pressure ulcers, myocutaneous m.gluteus maximus
flap with different pivotal point is conducted. When
cutaneous flaps are used, various transfer methods
regarding directions of tissue movement are patterned.
These comprise transposition flaps (used in 10 patients),
unilateral rotation flaps (used in 8 patients), bilateral
rotation flaps (in 2 patients) and bipedicular flaps (in 2
patients). Transposition is a kind of pivotal flap where
pedicle with the donor site flap is transposed in order to
cover the adjacent defect. When a rotation flap is planned,
we raise flap from the surroundings and bring it by means
of rotation directly in the defect. Bipedicular flap has two
pedicles, large enough to reconstruct defect. At the end
of  operation, loose dressing is applied over the base
where blood  supply comes from and on contrary,
compressive dressing over the flap body in order to
prevent any hematoma formation that will compromise flap
viability. Vacuum drainage is employed compulsory in each
case. First redressing follows on the ward after 3-5 days
when the drain tube is taken out. Sutures are pulled out
after 10-16 days. Patient has to avoid pressure over
Table 2. Distribution of flap types used in reconstruction of pressure ulcers
Myocutaneous flaps  m.tensor fasciae lata flap             m.gluteus maximus flap
Total:30 (100%)  1 (12.5%)            7 (87.5%) 8 (27%)
Cutaneous flaps Transposition flap Unilateral rotation flap  Bilateral rotation flap Bipedicular flap Total:30 (100%)
Total: 22 (100%) 10 (45%)                8 (36%)           2 (9.5%)                     2 (9.5%) 22 (73%)
This table shows the frequency of the flaps we’ve utilized in our group and it points out that cutaneous flaps,
out of which transposition flap as subtype, are the most used.
operative field while lie on bad for at least 4-6 weeks
postoperatively; frequent patient repositioning and anti-
decubital mattresses    are conducted on regular base.
Subcutaneous low-weight heparin (enoxiparin)
administration follows for to prevent any vascular
compromitation of flap blood supply.
In one patient, two decubital ulcers on distinct
sites are present. While the one on sacral region is to be
treated with flap, the other on the trochanteric region is
sutured directly after the usual preoperative ulcer
preparation. Although not advisable, in selected cases
when dealing with small but deep ulcers, with good
adjacent skin quality and appropriate local environment,
direct closure can be utilized safely. Otherwise, among
other due to suture tension, suture line will dehiscence
and reconstruction is doomed to failure.
Follow up after hospital discharge is advised on
weekly basis first month, than monthly first half year and
gradually increasing the interval. Written advices for
prevention of recurrences are issued on discharge day.
Flaps used in reconstruction of decubital ulcer are
summarized in Table 2.
Results
Operations underwent satisfactory and each
patient took it well. When performing this surgery, it is
anticipated complications to occur. These can be divided
into early and late complications seen on follow ups. Early
complications occur on the ward in first two - four weeks
after surgery and these include:
- hematoma formation due to suction failure of the drainage
system in 5 patients (16.7%);
- infection in operative site in 3 patients (10%), all in cases
with hematoma;
- partial dehiscence in 5 cases (16.7%), three in cases with
postoperative hematoma;
- marginal flap necrosis in 4 cases (13.3%).
These complication are overlapping in same
patients and all in all occurred in totally 9 patients (30%),
out of which 6 were reconstructed with myocutaneous
flaps.  This rate, although as high as nearly one third of
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the cases, is reasonable, bearing in mind the sensitivity
and fragility of the patients treated. Hematoma was
drained properly through suture line holes. Infection
resolved by antibiotics, locally and systematically
administrated, as well as by evacuation. Partial dehiscence
and marginal flap necrosis were let to sanate by second
intention for a period and delayed suture applied. Wounds
in uncomplicated cases healed regularly in 14-18 days.
Average hospitalization stay was 26 days (range 15 – 58
days) and more the complications occurred, longer the
hospital admittance.
Discussion
Operative treatment of decubital ulcer is needed
in order to achieve good functional and aesthetic results
in patients, to improve patients’ quality of life and gain
fast wound healing in those who demand rehabilitation
process. Flap surgery is the mainstream for reconstruction
(9). Skin grafting can be used just as a temporary coverage
on clean granulated wound bed. Grafts’ lacking of
Fig. 1. Deep pressure ulcer, stage IV with dimension over
10cm2, in sacral region, in paraplegic 39 old female, with
concomitant diabetes mellitus, with clean wound bed
without any necrosis and infection,  ready for operation
Fig 2. Transposition flap used for covering sacral post-excision pressure ulcer defect
resistance to shearing and friction forces make them prone
to easy damaging, no matter how thick they are.(2) On the
other hand, flaps comprise health, thick tissue with their
own blood supply and innervation, thus resistance to
injury is as high as the normal tissue, promoting them as
best solution for defect reconstruction in decubitus
patients. Flaps might content different tissue types, with
or without muscle included and their bulkiness is what we
need when treat patient with pressure sore. The same
effect can be achieved by ablation of bone prominence.
Regarding the tissue composition, flaps can be
fasciocutaneous and musculocutaneous. Type of the flap
to be used, depends on the region, the gross of the defect
and its depth. In the sacral region, flaps to be considered
as an option are unilateral or bilateral rotation
fasciocutaneous,  musculocutanous of m. gluteus
maximus  or transversal lumbo-sacral flaps.
Musculocutanous flaps with m.gluteus maximus, m.
semitendinosus, m. semimembranosus or m. biceps femoris
or just  fasciocutanous flaps might be used when
Tudzarova Gjorgova S. Surgical treatment of pressure ulcers
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reconstruction of ischiadic pressure ulcer is planned. In
trochanteric region, m.fascia lata musculocutaneous flaps
as a rotation flap could be in mind, but also random
vascularisation rotational or transposition cutaneous
flaps. Free skin grafts are usually applied for covering
donor site defects (10). Comparing to musculocutaneous,
local fasciocutaneous flaps as less aggressive
reconstruction method, seem to be more feasible in these
patients considering their often present malnutrition and
anemia thus less affecting their overall health condition.
Ablation of bone prominence  is advised in order surgically
to prevent recurrence after reconstruction if bulky flap is
not to be used. Bulky flap should always include muscle.
If myocutaneos flap and bone ablation are combined, the
chances for postoperative ulcer recurrence are by far
decreased. This two tools cannot be always combined. In
patients with pressure sores, that are often critically ill,
with limiting primary illness, operative risk higher that
others and present comorbidies, less aggressive and
shorter surgery is warranted. In that case, bone ablation
with an usage of local cutaneous flaps insures adequate
and satisfying results still more that myocutanous flaps
are burdened with higher complication rate as seen in our
study. When utilized cutaneous flap, corrective bone
ablation of the site of ulcer is compulsory. When closing
the donor site, directly or with skin grafts, must be paid
attention to bone ablation of the donor site if present. For
instance, when using transposition flap, flap base has to
be over the tuber ischii cause that is the bulkiest part, or if
not, tuber ischii has to be ablated. On contrary, we form
iatrogenic  locus resistentio minoris for subsequent sciatic
ulcer development  (2, 10, 11, 12).
Surgical treatment of pressure ulcer is
complimentary with  other options for medical treatment
although its place is usually a final event. As already
mentioned, this treatment bears lot of efforts, engage huge
resources, it is complex, time-consuming and often
unpredictable with the results. It affects not only the
patient, but his/her family as well and has health, social
and ethical impact. Once occurred, it resolves slowly,
despite all measures employed, has high recurrence rate
and incidence constantly increasing with unfavorable
cost-effectiveness. Ulcer recurrence as late complication
is most devastating incident that could happen. Usually
it occurs after few months after operation. Bearing in mind
the complexity of treatment, all measures that will prevent
recurrence following successful closure are combined
starting immediately after transferring the patient from the
operating table to bed. Specialized support surfaces,
weight bearing devices, frequent self- hand lifting and
repositioning at least every 2 hours by medical stuff, daily
skin care and usage of skin protecting barrier ointments,
soft underneath pads etc. are some of them. Advices for
patient is of great importance and they have to be trained
to deal with preventive methods as well as to inspect skin
on daily basis for any impending necrosis. (9, 10) Ulcer
recurrence occurred in 4 patients (13%). When present, it
is harder to reconstruct; health tissue already used and
lacking donor site for new flap. As luck would have it, our
recurrences were superficial ulcers that cured
conservatively although very slowly.
It is estimated that just in USA, total medical
care treatment costs are about $11 billion, cardinal reason
being that decubitus is one of the most underrated medical
problem. Still, hospitalized patients have unreasonable
high development  risk, among which the intensive care
units patients  the highest. In many countries, hospital -
acquired  stage III/IV decubitus is declared as adverse
patients safety event, and if not presented prior hospital
admittance, its treatment is not a subject to reimbursement.
That is why, much more attention is payed on prevention
of pressure ulcers with a lot of comprehensive prevention
programs being implemented. First step is to determinate
who has over the average risk thus needing greater
support. Braden and Bergstrom designed the widely used
Braden scale which outflanks risk factors such are sensory
perception, mobility, activity, nutrition, moisture and
friction/share (13). According to risk, this scoring system,
divides patients into 4 groups: patients with mild,
moderate, high and very high risk. Many will agree that
this system is not comprehensive enough and doesn’t
asses other predictive factors, such are advanced age,
hypoproteinemia, prolonged intensive care unit stay,
severity of illness, low arteriolar pressure, diabetes mellitus,
sepsis, vascular abnormalities and other comorbid
conditions. Prevention continues with implementing many
other medical measures and devices that will reduce or
eliminate the main cause, overpressure on the surface.
These includes    specialized support surfaces
(antidecubital air-flowed mattresses), repositioning of the
patient every 2 hours despite usage of specialized beds,
daily skin care by keeping skin clean and free of urine/
feces, application of barrier skin ointments, frequent skin
quality evaluation, sufficient protein intake and good
nutritional status with diet supplements added, optimized
wound dressing if necessary. Unfortunately, despite all
measured utilized, pressure ulcer do develop. While stage
I/II ulcer, in general, heal spontaneously with adequate
non-surgical medical methods, stage III/IV ulcer do need
surgery and consultation with plastic surgery, who perform
pressure sore reconstruction, is necessary  (4, 9, 13).
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Conclusion
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Holistic and multidisciplinary approach includes
involvement of variety specializations, like surgeons
(general surgeons, neurosurgeons, plastic surgeons,
urologists), rehabilitation medicine specialists, social
workers, psychologists and psychiatrists  as well as
geriatricians and internists, all in order to improve patients’
general health, to prevent and treat pressure sores and to
support progress and attitude as much as possible. If
unnoticed and untreated, complications as infection,
sepsis, malnutrition, amyloidosis, malign degeneration and
squamous cell carcinoma (Marjolin ulceration) can follow
and finally, decubitus can lead to death.
Surgical treatment of the decubital ulcers,
adequate and on time applied, in combination with
appropriate pre- and post- operative care, gains satisfying
functional and aesthetic results. That applies especially
in selected patients where primary illness as reason for
pressure ulcer is prone to successful rehabilitation.
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